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T-cells use the endocytic pathway for key cell biological functions, including receptor
turn-over and maintenance of the immunological synapse. Some of the established
players include the Rab GTPases, SNARE complex proteins, and others which in non-Tcell systems function together with Eps15 Homology Domain-containing (EHD) proteins.
To date, the role of the EHD protein family in T-cell function remains unexplored. We
generated conditional EHD1/3/4 knockout mice using CD4-Cre and crossed these with
mice bearing a myelin oligodendrocyte glycoprotein (MOG)-specific TCR transgene. We
found that CD4+ T-cells from these mice exhibited a reduced antigen-driven cell
proliferation and IL-2 secretion in vitro. In vivo, these mice exhibited reduced severity of
experimental autoimmune encephalomyelitis. Further analyses showed that recycling of
the TCR-CD3 complex was impaired, leading to increased lysosomal targeting and
reduced surface levels on CD4+ T-cells of EHD1/3/4 knockout mice. Our studies reveal a
novel role of the EHD family of endocytic recycling regulatory proteins in TCR-mediated
T-cell functions.
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CHAPTER 1: INTRODUCTION

2
1. Endocytic Trafficking
1.1 Overview
Endocytic trafficking is an essential cellular process that has been evolutionarily conserved,
from yeast to humans, with minor changes and specifications depending on the species. The
endocytic trafficking is a fundamentally complex system extensively used in physiologically
crucial processes such as cell migration (Maritzen, Schachtner, & Legler, 2015; Paul, Jacquemet,
& Caswell, 2015), receptor turnover (Irannejad, Tsvetanova, Lobingier, & von Zastrow, 2015),
cell signaling (Barbieri, Di Fiore, & Sigismund, 2016; Irannejad et al., 2015; Platta & Stenmark,
2011; Villasenor, Kalaidzidis, & Zerial, 2016), and cell-to-cell communication (Onnis, Finetti, &
Baldari, 2016). It is also used in other pathways such as pathogen invasion (Kulpa et al., 2013;
Pirooz et al., 2014; Takeuchi, Furuta, & Amano, 2011), cell division (Chesneau et al., 2012;
Schweitzer, Sedgwick, & D'Souza-Schorey, 2011), and membrane remodeling (Matsubayashi,
Coulson-Gilmer, & Millard, 2015). It is important to mention that mis-regulation of endocytic
trafficking is linked to different diseases including chronic hepatitis B virus (HBV) infections
(Macovei, Petrareanu, Lazar, Florian, & Branza-Nichita, 2013; Watanabe et al., 2007), cancer
(Mellman & Yarden, 2013; Mosesson, Mills, & Yarden, 2008), HIV infection (Kulpa et al.,
2013), and autoimmune diseases (Iglesias-Bartolome et al., 2009). Therefore, understanding how
this complex system works is of great interest in basic and clinical immunology.
Directed cell migration is an important phenomenon in embryonic development (Keller,
2002; Petrie, Doyle, & Yamada, 2009; Wallingford, Fraser, & Harland, 2002), during metastasis
(Etienne-Manneville, 2008; Petrie et al., 2009) and during immune responses to pathogens or
transformed cells (Petrie et al., 2009). For instance, immune cells are known to circulate in the
blood and through chemotactic gradients released during inflammation to migrate to the site of
infection. This very specific extravasation is achieved with the help of chemokine receptors,
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growth factor receptors, and adhesive integrins (Maritzen et al., 2015). Integrins are one of the
most important molecules required for, and are in the center of, cell migration.
Recent studies have shown that endocytic trafficking can regulate integrin functions.
Integrins are known to continually and rapidly internalize and recycle back to the plasma
membrane. For instance, some integrins were shown to internalize almost all their surface pool in
just 30 minutes (Paul et al., 2015) and with a low degradation rate, most recycled back to the cell
surface. This is important because as cells migrate, they form a rear and a front part, causing
integrins to act as “feet” that allow the cells to move forward. It has been suggested that migrating
cells use the process of endocytosis to move a pool of integrin “feet” from the rear of the cells to
re-distribute them through exocytosis or by recycling them to the front part of cells to cause the
forward movement (Paul et al., 2015). Other work has shown that this directional trafficking of
integrins actually happens in three different ways, in which they can be trafficked from the front
to the front, from the front to the rear of the cells, and from the perinuclear region to the rear of
the cells (Paul et al., 2015). Endocytosis of integrin does not only promote the disassembly of
adhesion, but it also contributes to the formation of adhesion reassembly by segregating a pool of
integrins that can be recycled where new adhesions have to be made (site of action) (Paul et al.,
2015). Lymphocytes use LFA-1 as their main integrin. The interaction between LFA-1 and its
ligand, ICAM, allows T-cells to migrate into peripheral lymph nodes and to interact with antigen
presenting cells (APCs) for T-cell activation (Evans et al., 2009). However, beside integrin, Tcells also need other receptors (such as co-stimulatory and co-inhibitory receptors and antigen
specific receptors) for proper immune response. All of these receptors are strictly regulated by
endocytic trafficking.
Immune cells have to maintain a proper balance between receptors on their cell surface and in
the intracellular pool to function properly. Hence, they have to regulate and balance the rate of
internalization, degradation, recycling and synthesis of new receptors. In most cases, the fate of
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most receptors is determined by the status of their signaling. Receptor signaling begins at the
plasma membrane; however, cells have found a way not only to sustain it, but also to terminate it
through the process of endocytic trafficking (Irannejad et al., 2015). After ligand binding,
receptors get activated mainly through phosphorylation of their cytoplasmic domain(s), which
leads to activation of signaling cascades that eventually leads to different outcomes such as cell
proliferation, survival, etc. Ligand binding induces internalization of receptors. These receptors
go from the plasma membrane to early endosomes (EE) where they are sorted to either go to the
lysosomes for signal termination or go back to the cell surface for re-stimulation. It is wellestablished that after internalization, a percentage of signaling receptors go from the EE to the
multi-vesicular bodies (MVB) where they get sorted to go to the lysosome for either receptorligand degradation or for ligand degradation (Villasenor et al., 2016). Research also shows that
another percentage of signaling receptors go from the EE to the cell surface using the fast route or
the slow recycling route in which receptors go from the EE to recycling endosomes (RE) first and
then back to the cell surface. All these steps are strictly regulated by families of endocytic
trafficking regulators such as Rabs and EHD protein families that will be discussed later.
Endocytosis is important for segregating a pool of signaling receptors from the plasma
membrane to the intracellular milieu to make space for new receptors and to allow signaling
termination. Endocytosis also creates endosomes with pools of receptors that are ready to go back
to the cell surface to sustain signaling at the cell surface and those that can act as a platform of
intracellular signaling (Barbieri et al., 2016). Research has shown that receptors are able to
continue signaling even inside endosomes in the intracellular milieu. In T-cells, internalized
TCRs have been shown to continue signaling in endosomes, therefore expanding the overall time
of sustained signaling (Yudushkin & Vale, 2010).
The endocytic trafficking is important in cell-to-cell communication especially among
immune cells. Research has shown that during contact between a T-cell and an antigen
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presenting cell (APC) or a target cell (which can be a transformed cell), they form a contact site
called the immunological synapse (IS).
The IS has been shown to be not only a site of intense internalization and recycling, but also
of directed secretions of cytokines, granzymes, microvesicles, and exosomes (Gutierrez-Vazquez,
Villarroya-Beltri, Mittelbrunn, & Sanchez-Madrid, 2013). Exosomes in particular, have been
shown to be bidirectional. Various studies have shown exosomes from APCs endocytosed in Tcells and vice versa. Other studies have also suggested that when engaged T-cell antigen
receptors (TCRs) are internalized, some take with them the antigenic peptide or the pMHC inside
the endosomes and when they are recycled, some of those are re-expressed on the cell surface of
the T-cells. Re-expressed antigenic peptides or pMHC can act as APCs in those regions and
activate other T-cells (a process called cross-dressing) (Campana, De Pasquale, Carrega,
Ferlazzo, & Bonaccorsi, 2015; Game, Rogers, & Lechler, 2005; Tatari-Calderone, Semnani,
Nutman, Schlom, & Sabzevari, 2002). Other exosomes carry with them other important
molecules including small RNAs that were shown to change T-cell profiles (Gutierrez-Vazquez et
al., 2013).
In addition, cell-to-cell communication is also exploited by certain pathogens. HIV for
example uses the virological synapse (VS), which is very similar to the IS, as a way to replicate
itself. Infected CD4+ T-cells form VS with other immune cells, including healthy CD4+ T-cells;
vesicles containing HIV have been shown to be secreted into the VS and endocytosed by target
cells. This newly infected cell can then form other VS with other healthy cells and spread the
virus (Alvarez, Barria, & Chen, 2014).
Regardless of which way the cell chooses to utilize the endocytic trafficking pathway, they all
involve the internalization of materials through the invagination of the plasma membrane into the
cytoplasmic milieu. This mainly involves the pinching of the plasma membrane, and then the
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release of the endosome containing internalized materials into the cytoplasmic milieu. Once in the
cytoplasm, depending on their fate, the materials are sorted into specific endosomes. In the case
of receptors, they either can go to the lysosomes for degradation or can recycle back to the cell
surface for other rounds of activation.
1.2 Routes of Endocytosis
Cells use endocytic trafficking for many functions, including the internalization of
receptors and uptake of nutrients, ligands, viruses and molecules. Cells use different routes to
endocytose materials that include the clathrin-dependent pathway and the clathrin-independent
pathway. The clathrin-independent pathway is further classified into caveolin-dependent, and
clathrin-and caveolin-independent, ARF6 endocytosis (Fig 1.1). Regardless of the pathway, the
internalized receptors enter the early endosome (EE) where they are sorted for either traffic into
late endosome/MVB and lysosome or for recycling back to the cell surface. The latter proceeds
either through the fast recycling route (directly to the plasma membrane) or through the slow
recycling route via the endocytic recycling compartment (also called recycling endosome) (Gould
& Lippincott-Schwartz, 2009; Jovic, Sharma, Rahajeng, & Caplan, 2010) (Fig 1.1).
Clathrin-mediated endocytosis (CME) is the most studied form of entry into the
cytoplasm and it is used by all eukaryotic cells. This pathway has been extensively studied for the
traffic of receptor tyrosine kinases (RTKs) such as EGFR and for G protein-coupled receptor
(GPCRs). CME is defined by uptake of materials from the plasma membrane into the cytoplasm
of cells through clathrin-coated vesicles. Five steps lead to the formation of a clathrin-coated
vesicle (CCV). They include initiation (nucleation), cargo selection, coat assembly, scission, and
uncoating (McMahon & Boucrot, 2011). Nucleation is the first step in CCV formation, in which a
particular site in the plasma membrane is marked for invagination; it also involves the

recruitment of clathrin machinery to the site. The membrane-sculpting F-BAR domain-
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containing FCHo1 and 2 (FCHo1/2) proteins, together with other proteins, function as
nucleator of clathrin-coated pits (CCP). FCHo1/2 bind to the plasma membrane to mark the site
of CCV formation and recruit the scaffolding epidermal growth factor receptor substrate 15
(eps15) and intersectin (Henne et al., 2007; McMahon & Boucrot, 2011; Pechstein et al., 2010)
which in turn recruit AP-2. This complex is able to form membrane curvature even before the
recruitment of clathrin (Henne et al., 2007; Henne et al., 2010; McMahon & Boucrot, 2011).
Other proteins such as SGIP1 (Henne et al., 2010) and other adaptors besides AP-2 are also
involved in this step, and include AP180 and clathrin assembly lymphoid myeloid leukemia
(CALM) (Daumke, Roux, & Haucke, 2014). All of these initiation proteins associate at specific
sites in the plasma membrane that are enriched in phosphatidylinositol-4, 5-bisphosphate [PI (4,
5) P2] (Di Paolo & De Camilli, 2006) and mark those areas for clathrin recruitment and assembly.
The next step is the cargo selection in which cargos with specific sequence are
recognized and bound to AP-2 and other cargo-specific adaptor proteins. CME is the only
endocytic pathway with very well-characterized cargos. It has been shown that the destination of
individual receptors and other membrane proteins depend on their intrinsic sequence-based signal
motif located in the cytoplasmic domain (Traub, 2003). These internalization signals are required
for transmembrane protein fast endocytosis (Traub, 2003). Transmembrane proteins are known to
bind directly to the µ2 subunit of AP-2 (4 subunits: α and β2 adaptins, µ2 and the σ2) (Ohno et
al., 1995). AP-2 recognizes and interacts with cargos containing sequences such as the YXXØ
(where X is any amino acid and Ø is a bulky hydrophobic residue) and [DE]XXXL[LI] dileucine
signals (Traub, 2003). Some cargos may also contain motifs such as the Asn-Pro-X-Tyr sequence
(NPXY) that are recognized by other clathrin adaptor proteins (Traub, 2003).
After the selection of the cargos that are to be internalized, clathrin triskelia are then
recruited from the cytosol of the cell to the site of the CCP on the plasma membrane by AP-2 and
other accessory adaptor proteins to help form the CCV. Clathrin triskelia concentrate in those

8
CCP forming clathrin lattice; their polymerization stabilizes the curvature, cargo-specific
adaptors and curvature effectors such as eps15 and intersectin. After their maturation, the CCV
pinch off from the plasma membrane through the help of dynamin, recruited by BAR domaincontaining proteins. These proteins have a preference in forming the curvature of necks for the
forming vesicles, and are suggested to help in the process of neck formation of the vesicles that
dynamin pinches off. These proteins include amphiphysin, endophilin, and sorting nexin 9
(SNX9) (McMahon & Boucrot, 2011; Meinecke et al., 2013).
After the scission by dynamin, the newly formed CCV is found in the cytosol, but before
it can fuse with the early endosomes, they have to be stripped of their coats. CCVs go through a
process of coat disassembly, by which the clathrin lattices go from an arranged conformation to
individual triskelia by the help of the ATPase heat shock cognate 70 (HSC70) and its cofactor
auxilin (Krantz et al., 2013). The triskelia are recycled for other CCV formation. The uncoated
internalized endosome can now fuse with the early endosome where the cargos are sorted
according to their fate.
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Figure 1.1: Pathways of Endocytosis. Different routes of endocytosis include the clathrindependent (CME), caveolin-dependent (CavME), and the clathrin- and caveolin- independent
internalization. Regardless of the route of internalization, the budded vesicle fuses with the EE
where they are sorted to either recycle back to the cell surface or go to the late endosome for
degradation. [(Gould & Lippincott-Schwartz, 2009) with permission from the publisher]
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In addition to CME, cells also use other pathways for entry of materials into the
cytoplasm that are called clathrin-independent endocytosis (CIE). CIE includes mainly caveolaedependent (clathrin-independent) endocytosis and both clathrin- and caveolae- independent
endocytosis called the Arf6 endocytosis (Maldonado-Baez, Williamson, & Donaldson, 2013).
Caveolae-mediated endocytosis (CavME) is defined as flask plasma membrane
invagination of 60-80 nm diameters that are abundant in most eukaryotic cells. Caveolae are
associated with cholesterol-rich lipid-raft domains and some glycosphingolipids and
sphingomyelins (Parton & Simons, 2007); they are used more extensively in some cells (such as
adipocytes and endothelial cells) than others. Caveolae pits are made of proteins from the
caveolin family, with Caveolin-1 (Cav1) being the most important. These proteins have been
shown to work in association with the cavins family of proteins (Elkin, Lakoduk, & Schmid,
2016; Parton & Simons, 2007; Parton & del Pozo, 2013).
CavME is different from other CIE in a couple of ways: i) CavME do not show a defined
coat structure (electron dense coat) as seen in CIE, nor show progression of neck formation
during cargo internalization; and ii) unlike clathrin, caveolae are differentially expressed in some
tissues and cells. Caveolae have been shown to make up about 50% of the plasma membrane
surface in cells such as adipocytes and endothelial cells. Even within a particular cell, caveolae
were preferentially shown to concentrate more in one area than another (Parton & del Pozo,
2013). For example, Cav1 homo-oligomers were shown to accumulate at the apical site while
Cav1 and Cav2 hetero-oligomers were accumulated at the basolateral side of epithelial cells. In
addition, Cav1 was shown to concentrate at the rear end of endothelial cells during planar
movement (migration) and to co-localize with caveolae (Parat, Anand-Apte, & Fox, 2003).
It is believed that caveolin oligomers traffic to the plasma membrane. Cavin proteins are
also recruited there and stabilize caveolin oligomers. What recruits cavin to the caveolae site is
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not clear, but interactions with caveolae and CAV1 may play a significant role. CavME is less
defined compared to the CME; however, recent studies have linked it to signal regulation,
receptor localization and trafficking, and regulation of lipids trafficking and metabolism (Parton
& del Pozo, 2013).
As more studies have emerged on understanding the entry of materials into the cytosol of
cells, it has become clear that other alternative routes of entry exist besides CME and caveolaedependent pathways. These include newly discovered clathrin- and caveolae-independent
endocytosis with pits containing flotillins (e.g. uptake of cholera toxin and endocytosis of
glycosylphosphatidylinositol (GPI)-linked proteins) (Glebov, Bright, & Nichols, 2006), pathways
that involve small GTPases Rac1 and Cdc42, endophilin-dynamin- RhoA-dependent pathway
(e.g. Interleukin- 2 receptor endocytosis) (Lamaze et al., 2001), and the pathways that requires the
small GTPase called Arf6 (e.g. MHC-I) (Elkin et al., 2016).
Most cells use both clathrin-mediated and clathrin-independent endocytosis at the same
time depending on the need and the kind of receptor transported. Such communication was
observed in the case of Rab35 which is transported by the CME, but is required for the transport
of cargos through CIE (Dutta & Donaldson, 2015).
1.3 Endocytic Trafficking Endosomes
Regardless of the route of endocytosis, all vesicles containing internalized materials end
up in the EE where they are sorted to go to the lysosomes or to go back to the cell surface through
the fast route (directly to the cell surface) or through the slow route using the RE. The EE is a
very dynamic structure with the capacity of undergoing homotypic fusion. The EE is composed
of micro-domains of tubule extensions of approximately 60 nm in diameter and large vesicles of
approximately 400 nm in diameter. The EEs are each specialized for the sorting of specific
cargoes within minutes after their internalization, according to their fates, into sub-domains that
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will sort them to the RE for recycling back to the plasma membrane or to the MVB for
degradation. The acidification of vesicles from these two different sub-domains also varies with
approximate pH ranging from 6.2 to 5.5 in the lumen of MVB and a pH of 6.5 in the tubular
recycling endosomes (Jovic et al., 2010). In addition, the pH in the lumen of EE is approximately
6.3-6.8 and allows the dissociation of most ligands from their receptors. An example of this is
seen in the case of the low density lipoprotein receptor that dissociates from its ligand (low
density lipoprotein) in the EE after internalization, and the receptor is sorted into a tubular subdomain for recycling while the ligand is sorted into the larger vesicle sub-domain for degradation.
The opposite is seen in the case of ligand-bound EGFR that is sorted together with the ligand into
the more circular or large vesicle sub-domain for degradation.
Internalized materials, including signaling receptors that are targeted to go back to the
cell surface, are sorted into micro-domains in the EE that are constantly forming tubules. Those
tubules containing cargo are labeled with Rab4 and Rab5 and, can either go back directly to the
plasma membrane using the fast route or can fuse with or differentiate into recycling endosomes
(RE) to go through the slow route (Jovic et al., 2010). When stained with Rab11, for example,
REs showed perinuclear localization. A good example of a signaling receptor that goes through
both recycling pathway is the transferrin receptor (TfR). Studies that measured the recycling of
TfR confirmed the existence of a slow (t1/2=15-30 minutes) and a fast route (t1/2= 5 minutes) for
recycling with different kinetics (Hopkins & Trowbridge, 1983; Swiatecka-Urban, 2013). This
tubular compartment is usually marked by the presence of Rab11 and/or EHD1, which will be
discussed in another sub-chapter.
The RE is not only important for the recycling of receptors, but it is crucial to sustain
signaling at the plasma membrane. It is required for antigen presentation by APCs, for the
maintenance of the immunological synapse necessary for proper immune responses, for the
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maintenance of cell polarity in polarized cells, for cell division, for migration, and for neuronal
synapse and neuron survival.
Receptors in the EE to be degraded have a sorting signal that allows them to be targeted to
the lysosome. For signaling receptors including the epidermal growth factor receptor (EGFR), a
mono-ubiquitination of one or more tyrosine residues in their cytoplasmic domain is required for
their targeting to the lysosomes. It is believed that receptors targeted to the lysosome accumulate
in areas in the EE that are rich in flat clathrin lattice. The hepatocyte growth factor-regulated
tyrosine kinase substrate (Hrs) in the EE binds ubiquitinated cargo, clathrin in the flat lattice and
other proteins such as the tumor susceptibility gene (Tsg)101 subunit of endosomal sorting
complexes required for transport (ESCRT-I), that in turn recruit ESCRT-II and ESCRT-III.
Together they bud off the EE and form the multivesicular bodies (MVB), which are somewhat
rounded and will then fuse to the lysosome for the degradation of the signaling receptor (Jovic et
al., 2010).
Another pathway that bridges from the EE is the retrograde transport to the Golgi complex.
Cargoes from the EE targeted to the trans-Golgi network (TGN) are sorted into tubular subdomains similar to those used for the recycling. The differences between these two tubular subdomains are that those used for the TGN are from more mature EE, are enriched with
SNX1/sortilin and show the presence of the retromer machinery with a high concentration of
phosphatidylinositol 3, 5-bisphosphate (PtdIns (3, 5) P2) generated by phosphoinositide kinase,
five-type zinc finger containing (PIKfyve kinase) (Jovic et al., 2010; Mari et al., 2008; Rutherford
et al., 2006). Caveolin-1 serves as a marker of endosomes in the transport of cargo from the
plasma membrane to the Golgi complex (Nichols, 2002).
EEs are not just important in sorting and directing cargoes to specific endosomes for their
fate, they are also important in signaling. Different GPCRs, such as thyroid-stimulating hormone
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receptor, have been shown to regulate signaling of MAPK and PI3K signaling pathway and the
production of secondary passengers such as cAMP while inside EE (Calebiro et al., 2009).
Recent studies have shown other kinds of recycling beside the typical slow and fast route of
recycling, well-described with the traffic of TfR. It was shown that the RE that recycles TfR is
different than the more tubular RE that are seen in the recycling of CIE cargoes such as MHC-I
(Swiatecka-Urban, 2013). Although, in both cases, these endosomes are positive for some similar
markers such as Rab11; they also have more specific markers such as Arf6 that mark them more
specifically for one type of cargo than the other. Cells have to maintain a proper balance between
the rates of internalization, degradation, recycling and synthesis for normal function. The
endocytic trafficking pathways involves the uptake of various materials including receptors
(which were described above), nutrients, pathogens, and more. Despite the most common and
well-studied pathways of endocytic trafficking mentioned above, other pathways exist such as
phagocytosis of large particles (used mainly by APCs), pinocytosis, and trogocytosis that are all
strictly regulated and used by cells for various reasons.
2. Regulators of the Endocytic Trafficking
2.1. Rab GTPases.
Endocytic trafficking is a very complex process with defined steps that are strictly
regulated by a small number of protein families including the Ras-associated binding (Rab)
proteins. Rab proteins are evolutionarily conserved proteins that are present in organisms ranging
from yeast to humans. For many decades, the Rab proteins have been shown to be the master
regulators of different steps of the endocytic traffic including the transport to the cell surface, to
the MVB then to the lysosomes for degradation, and transport to and from the TGN. Rabs are
small (21-25 kDa) monomeric GTP-binding proteins that cycle between the active form (GTPbound) and the inactive form (GDP-bound). In their GTP-bound/active state, Rab proteins
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localize to intracellular membrane where they have been shown to recruit and interact with their
effectors. It is through these effectors that Rab proteins functions. Upstream regulators called the
guanine nucleotide exchange factors (GEFs) in the cytoplasmic surface of different membranesbound organelles control the active or GTP-bound state of Rabs. GTPase activating proteins
(GAPs) (Bhuin & Roy, 2014; Jovic et al., 2010; Wandinger-Ness & Zerial, 2014) regulated the
inactive or GDP-bound state of Rabs, causing the hydrolysis of the Rab-GTP complex,
converting it into Rab-GDP, and causing its release from the target membrane to the cytosol.
Rab proteins that are known to localize in the EE include Rab5, Rab4, and most recently
classified Rab35; all playing different functions in the EE. Rab5 regulate the entry of vesicles
containing internalized cargoes from the plasma membrane to the EE. Rab5 is also important for
the generation of phosphatidylinositol-3 phosphate (PtdIns (3) P) lipids, for homotypic fusion and
for the movement of sub-domains of EE on actin and microtubules tracks. Some of Rab5
effectors include PtdIns (3) P-Kinase/h VPS34/p150 (VPS34), early endosomal antigen-1
(EEA1), rabenosyn-5, and APPL1 and APPL2 (Jovic et al., 2010).
Rab4 and Rab35 are regulators of the traffic pathway that localize in the EE. Both Rab4
and Rab35 regulate the transport or exit of constitutively and specialized recycling cargos from
the EE directly back to the plasma membrane using the fast route. In addition, Rab4 is shown to
regulate the exit of cargo from the EE to the RE for slow recycling. Key effectors of Rab4 include
rabenosyn-5, rabaptin-4, rabaptin-5 and rabaptin-5β. Rab35 is more associated with the recycling
of cargoes that were internalized through CIE. Cargoes trafficking in Arf6-positive endosomes
are positive for Rab35, but not Rab4, indicating that Rab35 is more associated with the recycling
of cargo from CIE (Chesneau et al., 2012; Etienne-Manneville, 2008; Walseng, Bakke, & Roche,
2008). Other Rabs (less studied) that also localize at the EE include Rab10, Rab14, Rab21 and
Rab22 (Jovic et al., 2010).
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Rab7 and Rab9 regulate the transport in the late endosome. Rab7 is now commonly used
as a marker for late endosomes that mature into or fuse with the lysosomes. Rab9 has been shown
to be more associated with the transport from late endosomes to the trans-Golgi. Another
important group of Rabs is the Rab11 protein. Rab11, together with Rab4, and Rab35 mediate
the recycling of cargo to the cell surface; however, Rab11 localizes in the RE and is more specific
for cargoes going through the slow recycling. Rab11 regulate the recycling of cargoes from the
EE and the transport of cargoes from the Golgi complex (Goldenring, 2015; Jovic et al., 2010).
Rab11 effectors include rabphilin11, Rab11 binding protein (Rab11 BP), family interacting
protein2 (FIP2), FIP3, FIP4, secretory protein 15 (Sec15), and Rab interacting protein 11(RIP11).
Other regulators of the endocytic trafficking in addition to the Rab family of GTPases are within,
the EHD-containing protein family (Zhang, Naslavsky, & Caplan, 2012).
2.2. EH Domain-Containing Protein Family
The EH domain was originally identified in 1993, as a three repeat sequence in the NH2terminal of eps15 (EGFR pathway substrate clone.15) (Fazioli, Minichiello, Matoskova, Wong, &
Di Fiore, 1993), and later on the same repeats were identified in another EGFR substrate called
eps15R (Coda et al., 1998). Since then, the number of proteins identified as containing this
domain has increased, and is now estimated to be over 50 EH domain- containing proteins
discovered, that include intersectin, Resps1, POB1, END3P and others (Fig 1.2). This domain is
important for protein-protein interaction and has been observed in organisms ranging from yeast
to humans. Most EH domain-containing proteins have more than one repeat of this domain in
their NH2 terminus, but neither the position of this domain nor the number of repeats appears to
be a requirement for function (Fig 1.2). The EH domain has a preference of binding to proteins
with asparagine-proline-phenylalanine (NPF) motifs such as Numb I. Studies have also shown
that the positions of amino acids around this motif are important for this protein-protein
interaction (Fazioli et al., 1993; Santolini, Salcini, Kay, Yamabhai, & Di Fiore, 1999).
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Most of the well-studied EH domain-containing proteins such as eps15 and intersectin are
mainly involved in the early steps of endocytosis and are shown to be critical regulators of
endocytic traffic. In addition to the NH2-terminal EH domain-containing proteins, a family of
proteins (as a sub-family of the EH domain proteins) was discovered that expresses only one
repeat of the EH domain located in the COOH-terminus and, is also involved in the endocytic
traffic, called the EHD protein family.
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Figure 1.2: Architecture of EH Domain- Containing Proteins. There are now over 50 proteins
in this family of EH domain-containing proteins. The structures of a few of them are shown here.
Most of them contain more than one repeat of the EH-domain on their N-terminus. The EHdomain is for their interaction with other proteins that contain NPF motifs. [(Santolini et al.,
1999) with permission from the publisher]
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3. EHD Protein Family
3.1 EHD Protein Structure
EHDs are evolutionarily conserved proteins that include four members (EHD1-4) in
mammals and one member in Caenorhabditis elegans, Drosophila melanogaster, plants such as
Arabidopsis thaliana, and in eukaryotic parasites such as Plasmodium falciparum, Leishmania
major and Entamoeba histolytica (Daumke et al., 2007). In mammals, EHD1 was the first
member characterized, before the discovery of the other three members, EHD2, EHD3, and
EHD4 (Mintz et al., 1999; Pohl et al., 2000). Based on nucleotide sequence alignment, EHD1 and
EHD2 have about 74% homology, up to 82% homology between EHD1 and EHD3, and up to
76% homology between EHD1 and EHD4 (Pohl et al., 2000). This family of proteins also has
very similar amino acid sequence and protein structure. These results suggest that EHD3 is the
most similar to EHD1 compared to the other members. Genes encoding these proteins were
mapped to different chromosomes with EHD1 to 11q13, EHD2 to 19q 13.3, EHD3 to 2q21 and
EHD4 to 15q11.1 (Pohl et al., 2000).
EHD proteins are ubiquitously expressed in most mouse organs analyzed, but show
differences in expression levels in various tissues. For example, EHD1 is highly expressed in
lung, spleen and in testis, but low in the kidney and liver. EHD2 is high in lung, mammary
glands, and fat tissues, but is either low or not expressed in kidney and in brain. EHD3 has a high
expression in heart, but has a low expression in the lung and liver. EHD4 is highly expressed in
the heart and pancreas, but has a low expression in the mammary glands and liver (Mintz et al.,
1999; Pohl et al., 2000).
All EHDs have three domains including the EH domain, the helical domain and the Ploop domain (also called the ATP/GTP-binding site) (Fig 1.3A). The EH domain is used for
protein-protein interaction and strongly binds to proteins with tripeptide asparagine-proline-
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phenylalanine (NPF) motif followed by two acidic residue (Daumke et al., 2007; Kieken et al.,
2010). These amino acids around the NPF motif have been shown to be critical for binding. A
conserved positively charged amino acid, lysine 483, is important for the function of the EH
domain. Mutation of this lysine to glutamic acid had no obvious defect on the structure of the EH
domain, but it caused a mis-localization of mutant EHD1 from tubular membranes to more
punctate structures. These results were similar to those seen when the entire EH domain was
truncated, suggesting a critical role of the EH-phosphoinositide interaction in membrane
tabulation (Naslavsky, Rahajeng, Chenavas, Sorgen, & Caplan, 2007). The coiled-coil domain
(helical domain) is for oligomerization and the P-loop (G-domain) binds and hydrolyzes ATP
instead of GTP. The P-loop is also required for dimerization and acts as the membrane-binding
region. The structure of EHD proteins also shows a linker region that connects the domains that
proceed the EH domain. The presence of an EH domain in EHDs suggested that they might have
a role in receptor-mediated endocytosis as shown with other EH domain-containing proteins such
as eps15 (Mintz et al., 1999).
Out of the 4 members, EHD2 and EHD4 are the only ones with a three-dimensional
protein structure resolved; however, the structure of the EH domain of EHD1 has also been
resolved (Fig 1.3B & Fig 1.4A). Studies on the characterization of the EHD2 structure provided
evidence that EHD proteins are involved in membrane remodeling in vivo and this task is ATP
dependent (Daumke et al., 2007). The study showed that EHD proteins have many similarities
with the dynamin superfamily including the ability to tabulate liposomes in vitro, to oligomerize
around lipid tubules in ring-like structures, and to hydrolyze nucleotide in response to lipid
binding (Daumke et al., 2007). Recent studies have characterized the structure of an N-terminally
truncated, activated EHD4 dimer (Melo et al., 2017). This group also performed a side-by-side
analysis comparing the non-activated/nonhydrolyzable ATP- bound EHD structure to the
activated EHD structure (Fig 1.3 and Fig 1.4).
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While in the cytosol, EHD proteins are in an auto-inhibited conformation, where the Nterminus is locked in the GTPase domain and the EH domains block assembly. However, once
recruited into the membrane, different conformational changes allow their functions. In the first
conformational change/rotation, the N-terminus of EHD proteins is released from the GTPase
domain; this was suggested to cause the activation of the EHD (Melo et al., 2017). The other
change is the rotation of the helical domains that adjust the position of the membrane-binding
site. This rotation seemed to regulate membrane binding. At the same time, this also causes the
linker to the EH domain to be freed from the GTPase domain. As a consequence, this then causes
the EH domain to become free compared to their inactive form. This was suggested to resemble
the interaction of an EH domain with an NPF motif binding protein such as MICAL-L1 (Melo et
al., 2017). Other conformations permit the formation and stabilization of EHDs oligomerization
at the membrane, and lead to membrane curvature ((Melo et al., 2017), Fig 1.4). EHD proteins
form homo and hetero-oligomers with the exception of EHD2 that appears to form only
homodimers. Other studies in mammalian cells have shown that EHD1 and EHD3 form homo
and hetero-oligomers, and EHD1 has been shown to form heterodimers with EHD4 in vivo (Yap,
Lasiecka, Caplan, & Winckler, 2010).
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Figure 1.3: Structure s of EHD Proteins. A) Generic structure of EHD proteins showing the 3
domains including the helical domain, ATP-binding-G-domain, and the EH-domain. B) Dimers
of EHD2 protein in the presence of a nonhydrolyzable ATP analog adenylyl imidodiphosphate
(AMPPNP). [(Daumke et al., 2007) with permission from the publisher]
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Figure 1.4: Structure of Activated EHD4 Dimers. A) Structure of the ATPγS-bound EHD4ΔN.
The purified N-terminally truncated EHD4 variant (amino acids 22–541). B) Activation model of
EHDs. Numbers refer to release of the N-terminus into the membrane (1), rotation of the helical
domain (2), release of the EH domains from the autoinhibitory site (3), insertion of the KPF-loop
into the hydrophobic pocket of the GTPase domain (4), membrane binding and oligomerization
(5), and membrane tubulation (6). [(Melo et al., 2017) with permission from the publisher]
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3.2 Functions of EHD Proteins in vitro and in vivo:
Since the discovery of all four members of the EHD protein family, interest in studying
their functions, both in vitro and in vivo, have increased. EHD1, compared to the other family
members, is the most studied and well-characterized. EHD1 has been described to regulate the
transport of various materials including signaling molecules from the early endosomes back to the
plasma membrane through the recycling endosome (Naslavsky & Caplan, 2011). However, some
studies associated the function of EHD1 to earlier steps of the endocytic trafficking (such as the
internalization of receptors) (Naslavsky, Rahajeng, Rapaport, Horowitz, & Caplan, 2007). EHD1
was first identified in a genetic screen that was looking for endocytic genes in Caenorhabditis
elegans. The investigators used a dominant-negative construct with a point mutation near the EH
domain and showed mis-localization of the endocytic RE and slowing of transferrin receptor
recycling (George et al., 2007; Lin, Grant, Hirsh, & Maxfield, 2001; Mintz et al., 1999).
EHD proteins are cytosolic proteins that are recruited to the endosomes through
interactions with specific lipids such as phosphatidic acid (PA) that are enriched in the endosomal
membrane. Recent in vitro studies (Giridharan, Cai, Vitale, Naslavsky, & Caplan, 2013) have
revealed that PA recruit MICAL-L1 (Molecules Interacting with CasL-Like1) and the F-BAR
protein Syndapin2 (Syn2, also called PACSIN2), to the RE and form a stable structure that is
involved in the curvature of the endosomal membrane and tubule formation by Syn2. EHD1 is
recruited to those tubules through a direct interaction with MICAL-L1. EHD1 also directly
interacts with Syn 2, so once recruited, EHD1 binds to both MICAL-L1 and Syn2, which then
performs vesiculation or scission of the pre-formed tubules (Braun et al., 2005; Giridharan et al.,
2013; Rahajeng, Giridharan, Cai, Naslavsky, & Caplan, 2012; Reinecke, Katafiasz, Naslavsky, &
Caplan, 2014). EHD1 mainly marks the RE and primarily exhibits perinuclear localization where
it has been shown to regulate the recycling of various molecules such as TfR, MHC-I, MHC-II,
β1 Integrin, and GLUT4 ((Caplan et al., 2002; George et al., 2007; Guilherme, Soriano,
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Furcinitti, & Czech, 2004; Jovic, Naslavsky, Rapaport, Horowitz, & Caplan, 2007; Lin et al.,
2001; Naslavsky & Caplan, 2011; Walseng et al., 2008), Fig 1.5).
The in vitro studies were instrumental in defining the mechanism of EHD proteins
functions in the endocytic trafficking pathway. In vivo studies of EHD proteins revealed that
these proteins are essential in fundamentally and physiologically relevant processes such as eye
development, embryonic development, muscle formation, and fertility. The EHD1 null mouse
was engineered in our laboratory and was found to be embryonically lethal in mice having a
predominantly B6 background (Bhattacharyya et al., 2016). Embryos from these mice were
studied in detail and they showed a neural tube closure defect. Further mechanistic investigation
showed short and stubby cilia with dysregulated ciliary SHH signaling due to a defective
transport of smoothened (a SHH receptor that was shown to be regulated by EHD1)
(Bhattacharyya et al., 2016). EHD1 null mice in a mixed 129:B6 background showed eye defects
including anophthalmia, aphakia, microphthalmia and congenital cataracts (Arya et al., 2015).
Another study showed that the lamprey I-EHD (conserved EHD1/3 ortholog) was found
to be enriched at the synaptic release site and to regulate the clathrin/dynamin-dependent synaptic
vesicle budding and dynamin function (Jakobsson et al., 2011). EHD1 has also been studied in rat
brains and found to negatively regulate synaptic vesicle exocytosis through binding to a protein
associated with synaptic vesicle called snapin (Wei et al., 2010).
EHD proteins have an EH domain that binds target proteins with an NPF motif followed
by an acidic residue. EHD1 has been shown to directly interact with proteins including, but not
limited to, Rab11 effector Rab11-FIP2, syndapin 1 and syndapin 2, snapin, SNAP29, rabenosyn5, and MICAL-L1. In addition to its well-known function in the RE, EHD1 has also been shown
to be associated with Rabankyrin-5 and Vps26 to regulate the retromer pathways (Zhang et al.,
2012).
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EHD2

Figure 1.5: Endocytic Trafficking of Signaling Receptors. This diagram has been modified to
show where in the endocytic trafficking pathway the EHD proteins seem to function. These
functions are based on various in vitro experiments from different groups and some confirmation
from some in vivo models. EHD proteins have been shown to play similar and distinct roles in
different steps of the endocytic trafficking pathway. [Modified from (Scita & Di Fiore, 2010)
with permission from the publisher]
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EHD3 is the closest to EHD1 in sequence identity. EHD3 has been studied in different
systems in vitro. Those studies have shown that EHD3 regulates the exit of cargos from the EE to
the RE (Naslavsky, Rahajeng, Sharma, Jovic, & Caplan, 2006) (Fig 1.5). Unlike EHD 1 that was
shown to cause scission of pre-existing tubules, EHD3 is important in endosomal membrane
tubulation (Henmi et al., 2016). EHD3 null mice do not have any overt phenotypes. However,
another group found EHD3 expression level increased during heart failure in large animals such
as dogs (Gudmundsson et al., 2012). EHD3 null mice also had cardiac abnormalities including
arrhythmias and blunted response to adrenergic stimulation, and reduced expression of Na/Ca
exchanger (NCX1) (Curran et al., 2014). In glioma cancer tissues, EHD3 was found to function
as a tumor suppressor by controlling cell cycle arrest and apoptosis (Chukkapalli et al., 2014).
EHD4 is involved in trafficking of the EE and control the exit of cargo from both the RE
and the late endosomes (Fig 1.5). To demonstrate the role of EHD4 in recycling, the Caplan
laboratory studied the effect on recycling of TfR and MHC- class I, and used low-density
lipoprotein to demonstrate its role in degradation (Sharma, Naslavsky, & Caplan, 2008). In
neurons, the neurotrophin (NT) family of target-derived growth factors controls neurons’ survival
in both the periphery and in the CNS by signaling through Trk receptor tyrosine kinase (which
has ligands such as TrKA, etc.). EHD4, called Pincher in this study, was shown to regulate the
internalization of TrKA and TrKB, to associate with TrK endosomes in the MVB, and to regulate
their retrograde transport and signaling by associating with ErK5, a downstream effector of the
retrograde survival signaling (Valdez et al., 2005). To demonstrate the role of EHD4 in vivo, our
laboratory engineered EHD4 null mice. These mice showed that EHD4 was required for normal
pre-pubertal testis size in the male. These EHD4 null males had reduced fertility (George et al.,
2010). As seen with other EHD whole body knockout systems, EHD1 expression was high in
adult mice and, we believe, compensated for the loss of EHD4 in some organs.
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EHD proteins have been shown to have both shared and distinct roles in endocytic
trafficking (George et al., 2007), and these have caused their genetic studies to be confounded due
to their compensatory functions. While EHD3 null mice have no obvious phenotype, EHD3 and
EHD4 double knockout mice had smaller, pale kidneys, died at very young age (between 324weeks), and developed renal thrombotic microangiopathy (TMA)-like glomerular lesions
(George et al., 2011). Cadherin -23 (CDH23) and protocadherin 15 (PCDH15), members of the
cadherin superfamily, form some of the extracellular filaments that connect stereocilia and
kinocilium of a hair cell into a bundle (Muller, 2008). Deletion of CDH23 and PDH15 genes has
been associated with deafness. A study showed that EHD4 interacts with CDH23 in hair cells;
however, EHD4 null showed no defect in hearing suggesting a compensatory function for EHD1
as these mice showed a 2-fold increase in EHD1 expression (Sengupta et al., 2009).
EHD2 is the most distinct of all the other EHD proteins. EHD1, EHD3 and EHD4 are
located on intracellular tubular/vesicular membranes, while EHD2 is located to the cytoplasmic
interface of the plasma membrane. All EHDs form hetero-oligomers, except for EHD2 that only
forms homo-oligomers. EHD1 protein localization to the membrane depends on interactions with
MICAL-L1 and with phosphatidylinositol lipids, as the mutation in lysine 483 inhibits EHD1
localization to the tubular structures (Naslavsky et al., 2007). However, the localization of EHD2
to the plasma membrane is regulated by its interaction with phospholipid PIP2 and is independent
of actin microfilaments (Simone, Caplan, & Naslavsky, 2013). Based on its localization on the
cytoplasmic side of the plasma membrane and its association with phospholipids, studies were
done to determine whether EHD2 has any role in the early steps of internalization such as vesicle
formation. EHD2 was identified as a third structural element or component of the caveolae at the
plasma membrane and is involved in controlling the stability and turnover of the caveolae. EHD2
was also shown to interact directly with cavin1 and pacsin2/Syn2, such that its deletion resulted
in more dynamic and short-lived caveolae (Moren et al., 2012).
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EHD2 localization in the plasma membrane suggested possible actin interaction with
actin. One study connected EHD2 to the actin cytoskeleton through its interaction with EHBP1.
EHBP1 has a CH domain similar to that of the type 1 CH domain of α-actin, which binds F-actin
(Guilherme et al., 2004). Another study showed that EHD2 interacts with Nek3 and is associated
with Vav1, a Nek3-regulated GEF for Rho GTPases. Since Vav1 regulates Rac1 activity, this
study suggested that EHD2 regulates the traffic from the plasma membrane by controlling Rac1
activity (Benjamin et al., 2011). EHD2 is highly expressed in fat, and regulates the
internalization of Glut4 in adipocytes (Guilherme et al., 2004). EHD2 is involved in other
pathways besides the internalization of material from the plasma membrane (Fig 1.5). It directly
binds to the second C2 domain of myoferlin and regulate myoblast fusion (Doherty et al., 2008)
and, translocate to the nucleus as well as suppresses transcription (Pekar et al., 2012) and
accumulates at the site of injury in human myotubes during membrane repair processes (Marg et
al., 2012).
The EHD protein family is involved in various steps of endocytic trafficking including
internalization, endosomal sorting (at the early endosome, late endosome, and recycling
endosome), and retrograde transport. EHD proteins regulate the process as of cell migration,
embryonic development, muscle size regulation, fertility, synaptic release in neurons, and
receptor trafficking from the plasma membrane to their designated destination, and have more
recently been associated with diseases such as cancer and neurological disorders such as
Alzheimer’s (Buggia-Prevot et al., 2013; Chukkapalli et al., 2014). However, although studies
have shown the expression of EHD proteins in lymphoid tissues such as the spleen, prior to the
research described in this dissertation their role in T cell function had not been studied.
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4. T-cell Functions
4.1 Overview of T-cell Development
T-cell development starts in the bone marrow from hematopoietic stem cells. Some of the
stem cells give rise to the common lymphoid progenitors that differentiate into immature
precursor T-cells. The immature precursors migrate to the thymus and proceed through thymic
developmental stages. While in the thymus, they differentiate into a double negative stage (DN).
DN T-cells express neither CD4 nor the CD8 co-receptor. Based on surface expression of CD44
and CD25, the DN T-cells are further classified into DN1, DN2, DN3 and DN4. The DN stage
defines if the T-cell will express the αβ T-cell antigen receptor (TCR) or ƴδ TCR T cell lineage.
In the case of a αβTCR, the DN T-cell differentiates into the double positive stage (DP) where it
expresses both the CD4 and CD8 co-receptors. The DP T-cells go through positive and negative
selection to eliminate potential self-reactive T-cells. Both selections result in the generation of
single positive (SP) CD4+ and CD8+ T-cells. The SP cells then migrate to secondary lymphoid
tissues and interact with APCs that present antigenic peptide; this interaction leads to activation
and confers a defense against pathogens (Ellmeier, Haust, & Tschismarov, 2013; Sawada,
Scarborough, Killeen, & Littman, 1994). During T-cell activation, the contact site between the Tcells and APCs form a structural domain called the immunological synapse (IS) that is required
for an effective T-cell activation and effector functions.
APCs (including macrophages, dendritic cells and B cells) surveille tissues looking for
pathogens or dying cells. Loaded with antigenic peptides, they migrate from tissues to lymphoid
organs and present the peptides to T-cells, specifically CD4+ T-cells. APCs internalize antigens
through phagocytosis and/or receptor-mediated endocytosis. APCs then process those antigens to
small peptides that can be loaded into the MHC molecules. This process is called antigen
processing. The next step is the loading of those antigenic peptides into either MHC class I or
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MHC class II depending on the source of the antigen which come from either the extracellular or
the cytosolic environment for MHC class II or MHC class I, respectively. The peptides loaded
into MHC class II, for example, are transported to the cell surface and will present peptides to
CD4+ T-cells. On the other hand, T-cells also proceed through different steps and check points to
be ready to elicit a specific response to the particular antigenic peptide recognized (Neefjes,
Jongsma, Paul, & Bakke, 2011).
Naïve cells (unstimulated T-cells) are primarily stimulated by dendritic cells; this causes
the T-cell to proliferate and differentiate into effector cells. Priming of naïve cells is critical for
initiating T-cell responses against the pathogen; however, re-stimulation of effector T-cells
through a second exposure to the same antigen causes a faster and more robust response against
the pathogen. T-cell activation involves more than antigen recognition by antigen-specific TCRs
and co-receptors; requiring regulation by a variety of molecular interactions with costimulatory
and co-inhibitory molecules, cytokine receptors, adhesion molecules, and intracellular signaling
cascades.
4.2 T cell Activation and the Immunological Synapse (IS)
The TCR/CD3 complex is comprised of a TCR αβ heterodimer that is required and
responsible for antigen recognition, and the non-polymorphic CD3 proteins that are responsible
for initiating the intracellular signaling cascade. The CD3 protein is made of the heterodimers
γδ and γε and the homodimer ζ-ζ (Portoles & Rojo, 2009; Shores et al., 1994; Smith-Garvin,
Koretzky, & Jordan, 2009; Yuseff, Lankar, & Lennon-Dumenil, 2009). After ligand recognition,
Lck (a Src family tyrosine kinase) becomes activated and phosphorylates immunoreceptor
tyrosine-activation motifs (TAMs) within the cytoplasmic tail of the CD3 complex. This leads to
calcium signaling and recruitment of other tyrosine kinases such as Zap-70, that bind to the
phosphorylated ITAMs. Zap-70 in turn acts as a scaffolding protein and recruits signaling
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adaptors and effector molecules such as LAT, SLP-76, Grb2/Gads, and phospholipase C-y
(PLCY). Zap-70 also activates other signaling molecules such as protein kinase C-Ɵ (PKCƟ),
inducing cytokine production and controlling the activation of genes involved in T-cell survival
and effector functions (Hashimoto-Tane et al., 2010; Yuseff et al., 2009). T-cell activation in the
absence of co-stimulatory molecules causes the T-cells to become anergic (a non-responsive
state) which leads to failure of T-cells to respond to further re-stimulations. Interaction of costimulatory molecules such as CD28 with their ligands CD80 and CD86 provides additional
signaling required for avoidance of anergy and for productive T-cell activation (Smith-Garvin et
al., 2009).
The IS represents the site of contact between T-cells and APCs or target cells (e.g., tumor
cells). The IS is initiated early during T-cell activation and results in the accumulation of TCRs in
apposition with peptide-MHC on the APC. Signaling begins at the periphery of the IS with the
formation of microclusters that typically contain phosphorylated TCRs, associated signaling
molecules (e.g. Zap70, SLP-76, etc.), and co-stimulatory molecules (e.g. CD28) (HashimotoTane et al., 2010) (Fig 1.6). These microclusters are transported to the center of the IS and form
the central supra-molecular activation complex (cSMAC) (Fig 1.6). Other key signaling proteins
that localize to the cSMAC include Lck and LAT. The cSMAC is surrounded by an accumulation
of cell adhesion molecules which pair with counter-receptors on APC, such as LFA1-ICAM1,
forming a sealing zone called peripheral SMAC (pSMAC) (Griffiths, Tsun, & Stinchcombe,
2010; Hashimoto-Tane et al., 2010; Huppa, Gleimer, Sumen, & Davis, 2003; Jo et al., 2010), Fig
1.6). cSMAC is a site of both strong receptor activation and increased receptor degradation (Lee
et al., 2003).
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4.3. Endocytic Trafficking in T cells
Recent studies (Cemerski & Shaw, 2006; Finetti et al., 2009) have demonstrated that
clustering of TCRs at the IS is a combination of lateral diffusion, cytoskeleton-derived
movement, and polarized recycling. TCR/CD3 association starts at the ER and is completed at the
Golgi. From the Golgi, TCR/CD3 is transported through endosomal vesicles to the cell surface.
Several studies have shown that once the TCRs are on the surface, they undergo several rounds
through the constitutive recycling pathway before being targeted for degradation (Das et al.,
2004; Finetti et al., 2009; Lee et al., 2003). The TCR/CD3 complexes go through the CME for
internalization. Once internalized, they co-localize with TfR in the RE and in the IS, suggesting
that internalized TCRs traffic through the recycling endosome back to the cell surface (Das et al.,
2004).
It is well documented that T-cells become polarized during ligand activation, leading to
the rearrangement of intracellular organelles such as the recycling endosomes, the Golgi, and the
centrosome or MTOC directly underneath the IS (Yuseff et al., 2009). The main purpose of
MTOC/Golgi rearrangement is to direct secretion of Golgi-derived lymphokines from T-cells to
the bound APC (Poo, Conrad, & Janeway, 1988), and to allow trafficking of newly synthesized
TCRs from the Golgi to the surface. In addition, MTOC/Golgi rearrangement has also been
required for the delivery of granules to the IS, hence controlling the killer function of cytotoxic T
lymphocytes (CTLs) (Kloc, Kubiak, Li, & Ghobrial, 2014; Stinchcombe, Majorovits, Bossi,
Fuller, & Griffiths, 2006). Polarization of recycling endosomes is important for effective
accumulation of TCRs at the IS. Studies have shown that constitutive internalization and
recycling of TCRs are necessary for their accumulation at the IS (Das et al., 2004; Yuseff et al.,
2009). In some studies, internalization was seen as early as 6 min after T-cell-APC contact and up
to 90% of surface TCRs were internalized within 30-60 min after the contact (Huppa et al., 2003).
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Figure 1.6: Later Stages of the IS in T-cells: Vesicle Trafficking and Changes in
Polarization and Membrane Morphology Determines Effector Functions. Membrane
rearrangement leads to the formation of the cSMAC where immune-engaged receptors are
clustered and the pSMAC that contains adhesion molecules forms a seal that keeps the T-cell and
the APCs in contact during activation. [(Yuseff et al., 2009) with permission from the publisher]
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T-cell activation leads to phosphorylation of the ITAM in the cytoplasmic tail of CD3
proteins. Stimulation by a strong agonist triggers TCR internalization and degradation from the
cSMAC, which leads to the down-modulation of the TCR signaling (Lee et al., 2003).
Importantly, signal attenuation can also be caused by the function of co-inhibitory molecules such
as CTLA-4, which competes with CD28 for binding to CD80 (or B7-1) and CD86 (B7-2) and
disrupts tyrosine phosphorylation events through recruitment of intracellular SH-2 phosphatase
(Huppa et al., 2003). However, while degradation through the lysosome is still considered one of
the main ways of signal attenuation, some studies have shown that partially or slightly
phosphorylated TCRs recycle back to the cell surface after internalization, while fully
phosphorylated TCRs traffic to the lysosomes for degradation (Lee et al., 2003). These studies,
together with other studies demonstrated that a small portion of surface TCRs are recycled back
to the surface during activation, suggesting that the recycling endosome is a critical compartment
controlling the traffic of recycling TCRs and newly synthesized TCRs to the surface. Therefore,
the RE not only provides T-cells with TCRs that are ready for stimulation, but also at the same
time sustains signaling by controlling the formation and maintenance of the IS.
It has become clear and well accepted that the IS is a focal point of strong endocytic
trafficking (Griffiths et al., 2010) (Fig 1.6). Most of the molecules that are required for the
formation and maintenance of the IS such as TCRs (Huppa et al., 2003), CD28 (Cefai et al.,
1998), LFA-1 (Fabbri et al., 2005; Stanley, Tooze, & Hogg, 2012) on T cells and ICAM-I (Jo et
al., 2010), MHC class I (Caplan et al., 2002) and MHC class II (Walseng et al., 2008) on APCs
have been shown to undergo internalization and recycling back to the T-cell-APC interface
during activation. Besides receptors, signaling molecules such as LAT and Lck also traffic to the
IS (Soares et al., 2013); yet, the mechanisms of trafficking for most of these proteins are not well
understood.
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Endocytic trafficking in T-cells has been well studied in the context of T-cell activation
by either a ligand or antibodies (such as anti-CD3/CD28), but process of endocytic trafficking in
unstimulated (naïve or resting) cells has received little focus. A study showed that activation of
PKC induces internalization of TCR with subsequent sorting to a non-degradative compartment
from which the TCR recycles back to the cell surface in a functional state (Dietrich et al., 1998).
They also demonstrated that PKC-mediated internalization requires the phosphorylation of CD3ƴ
S126. The same group showed that de-phosphorylation of CD3ƴ following PKC-mediated
internalization was required for TCR recycling and it was dependent neither on microtubules and
actin polymerization nor on CD45 or Src kinases. Their study was among the first to suggest that
PKC-dependent and ligand-dependent TCR sorting are two different pathways of receptor
sorting. Their data also suggested that PKC-mediated TCR sorting via the RE is mainly used in
unstimulated T-cells (before ligand binding), which are known to constitutively internalize and
recycle their receptor with very little degradation as opposed to activated T-cells. During ligand
binding, both the PKC and tyrosine kinases are activated, but leads towards lysosomal sorting of
TCR; therefore, suggesting that ligand-dependent sorting is more dominant than PKC-dependent
sorting during activation (Dietrich et al., 1998).
4.4. Similarities Between IS and other Synapses
The IS exhibits various similarities with the neuronal synapse, and neuromuscular
Junction (Boulanger, Huh, & Shatz, 2001; Dustin & Colman, 2002; Tarakanov & Goncharova,
2009), both shown to be regulated by EHDs. EHD proteins were found to localize to and regulate
neural synapses (Ioannou & Marat, 2012) and were implicated in various steps of endosomal
trafficking in neuronal synapses (Ioannou & Marat, 2012; Lasiecka, Yap, Caplan, & Winckler,
2010; Valdez et al., 2005; Yap et al., 2010). EHD1, in particular, was found to negatively regulate
exocytosis in the vesicle release site by affecting the binding of the SNARE complex protein,
SNAP-25 to snapin, preventing the association of synaptotagmin-1 to the SNARE complex (Wei
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et al., 2010). SNAP-25 is also a t-SNARE expressed in T cells as SNAP-23 and shown to cluster
at the IS (Das et al., 2004). Another study showed that the lamprey I-EHD (conserved EHD1/3
orthologue) was found to be enriched at the synaptic release site and regulated the
clathrin/dynamin-dependent synaptic vesicle budding and dynamin function (Jakobsson et al.,
2011). Collaborative studies between our laboratory and the Hoffman group at George
Washington University demonstrated that endogenous EHD1 localizes at the neuromuscular
junction in vivo (Mate et al., 2012). The fact that the EHDs play important roles in other synapses
that have shown similarities with the IS suggest that they could also regulate the IS.
Several studies have suggested a link between the process of ciliogenesis and IS
formation (Griffiths et al., 2010). Our lab has found that the embryonic lethality observed in
EHD1 null mice is associated with open neural tubes, loss of primary cilia on neuroepithelial
cells, and defected ciliary SHH signaling due to a dysregulated transport of smoothened, a SHH
receptor shown to be regulated by EHD1 (Bhattacharyya et al., 2016). Importantly, SHH
signaling has been shown to control T-cell killing at the IS (de la Roche et al., 2013). In vitro
studies of EHD1-null MEFs confirmed the role of EHD1 in primary ciliogenesis (Bhattacharyya
et al., 2016). In addition, although hematopoietic cells lack primary cilia, an essential
intraflagellar transport (IFT) component, IFT20, was found to be expressed by T-cells and is
required for the recycling of the TCR/CD3 complex and other receptors that traffic to the IS back
to the surface (Finetti et al., 2009; Finetti et al., 2014). Furthermore, knockdown of IFT20
resulted in impaired recruitment and signaling at the IS.
4.5 Potential Role of EHD Protein Family in T cell Function and in the IS
EHD proteins regulate the recycling of a number of receptors that traffic through the
clathrin-dependent and clathrin-independent pathway, including TfR, MHC class I, MHC class II,
etc. (Caplan et al., 2002; Lin et al., 2001; Naslavsky & Caplan, 2011; Walseng et al., 2008).
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Furthermore, uncoordinated 119 protein (unc119) which regulate the activation of Rab11,
controls the exit of Lck, (a Src kinase that phosphorylates the ITAM of the TCR-CD3 complex
and is recruited to the IS) from Rab11 endosomes to the plasma membrane (Gorska, Liang,
Karim, & Alam, 2009), while the function of Rab11 is regulated by EHD proteins (George et al.,
2007; Naslavsky et al., 2006; Naslavsky & Caplan, 2011). Another study showed that the
recycling of LFA-1 is dependent on the traffic of ICAM-1 to the IS (Jo et al., 2010). Furthermore,
the same group demonstrated that ICAM-1 co-localized with MHC class II in intracellular
endosomes and at the APC side of the IS during ligand stimulation (Jo et al., 2010). These results
suggested that ICAM-1 uses the same traffic pathway as MHC class II, which has been shown to
be regulated by EHD1 (Walseng et al., 2008). These data suggest the possibility that EHD1 could
be responsible for the transport of both MHC class II and ICAM-1 to the IS on APCs during
ligand stimulation.
Based on the importance of the endocytic traffic in T-cell function and IS formation and
maintenance, we wanted to investigate the role of the EHD proteins in both T-cell function and in
the IS. Given the importance of the endocytic trafficking in T-cell function and in IS during
activation and the role of the EHD proteins in the neuronal synapse, in the neuromuscular
junction, and in ciliogenesis, we hypothesized that EHD protein will regulate the endocytic
recycling of receptors and the stability of IS/APC contact formation/maintenance in unstimulated
and activated T-cells, respectively.
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CHAPTER 2: MATERIALS AND METHODS
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2.5. Materials and Methods for Chapter 3

5.1 Reagents & Antibodies
Reagents: BSA (cat. # A7906-100G), paraformaldehyde (cat. # 158127-500G), Triton X-100
(cat. # 93418), EGTA (cat # E8145-50G), sodium orthovanadate (Na3VO4, cat # S6508-50G),
sodium deoxycholate (cat # D6750-100G), 4-hydroxtamoxifen (cat. # T176-10MG), and
Brefeldin A (BFA, cat. # B7651) were from Sigma-Aldrich (St. Louis, MO). Propidium iodide
staining solution (cat. # 00-6990-42) was from eBiosciences. 3H-thymidine (cat. # 2407001, 2.0
Ci/mmol) was from MP Biomedical. Bafilomycin A1 (cat. # BML-CM110-0100)) was from Enzo
Life Sciences. MOG peptide (amino acids 35-55) (cat. # BP001328-PRO-371) was from Syd
Labs. OVA peptide (amino acid 323-336) (sequence: ISQAVHAAHAEINE) was synthesized by
Tufts University Core facility (Medford, MA, 02155). CFA (cat. # 231131) and heat-inactivated
Mycobacterium tuberculosis were from DIFCO Laboratories. Sodium fluoride (NaF, cat # S299500), sodium chloride (NaCl, cat # S271-10), and Tris (cat BP152-5) were from Fisher
Chemicals. Pertussis toxin was from ENZO Life Sciences. ECL development reagent (cat. #
32106), BSA for bicinchoninic acid assay (cat # 23209), and PMSF (cat # 36978) were from
Thermo-Scientific. CFSE (cat. # C34554), CellTrace Violet stain (cat # C34557), RPMI-1640
(cat. # SH30027.02), Penicillin/streptomycin (cat. # 15140-122) and FBS (cat. # 10427-028; lot #
1662765A120-01) were from Life Technologies. Live/dead fixable blue dead cell stain kit was
from Molecular Probes. IL-2 ELISA kit (cat. # M2000) was from R&D Systems, Inc.
Antibodies: Anti-CD28 (cat. # 122007) and anti-LFA-1(cat. # 141011) was from Biolegend.
Anti-CD3Ɛ (referred to as anti-CD3) (cat. # 553064, and 553057), anti-CD25 (cat. # 558642),
anti-CD4 (cat. # 553051, and cat # 553047), anti-CD8α (cat. #560469), anti-CD28 (cat. #
553294) and anti-CD44 (cat. # 553135) was from BD Bioscience. Anti-B220 (cat. # 25-0452-81),
and anti-CD3Ɛ (referred to as anti-CD3) (cat. # 56-0032-80) were from eBioscience. Anti-HSC70
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(cat. #sc-7298) and anti-LAMP1 1D4B (cat. # sc-19992) were from Santa Cruz Biotechnology.
Anti-EHD1 (cat. # ab109311) was from Abcam. Anti-β-Actin (cat. # A5316) was from SigmaAldrich. APC-conjugated anti-Annexin V (cat. # 17-8007-72) was from eBiosciences. Polyclonal
rabbit antibodies recognizing EHD1 plus EHD4, EHD2 or EHD3 have been described previously
(45). Secondary fluorochrome-conjugated antibodies were from Life Technologies.
5.2 Mice Generation & Genotyping
Whole-body knockout mice (Ehd1-null) derived from Ehd1flox/flox mice have been described
previously (Rainey et al., 2010). Ehd1-null mice were maintained on mixed 129, B6 background.
EHD1fl/fl; EHD3fl/fl; EHD4fl/fl mice in a predominantly C57BL/6 background were crossed with
B6. Cg-Tg(Cd4-cre)1Cwi/BfluJ to generate Cd4-cre; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl mice. These
mice were further crossed with C57BL/6-Tg (Tcra2D2, Tcrb2D2)1Kuch/J, 2D2 Tcr or MOG Tcr
to generate Cd4-cre; 2D2Tcr; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl mice. EHD1fl/fl; EHD3fl/fl; EHD4fl/fl
mice in a predominantly C57BL/6 background were also crossed with tamoxifen-inducible
CreERT2-expressing mice from Jackson Laboratories (Gt(ROSA)26Sortm1(cre/ERT2) Tyj; strain
008463) to generate CreERT2; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl mice. These mice were further crossed
with C57BL/6-Tg (Tcra2D2, Tcrb2D2)1Kuch/J, 2D2 Tcr or MOG Tcr) to generate CreERT2;
2D2Tcr; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl mice. Genotypes were confirmed by subjecting tail clip
DNA to PCR analysis using the KAPA mouse genotyping kit (KAPA Biosystems). Mice were
treated humanely according to the National Institutes of Health (NIH) and University of Nebraska
Medical Center guidelines. Animal studies were pre-approved by the Institutional Animal Care
and Use Committee (#14-067).
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Table 2.5.3. Primers Used for Tail PCR Genotyping (include modification codes if applicable)
Oligo Names

Sequences 5’ to 3’

Ehd1-1

(AAGTCAGAAGACAACTTTCTGGAGTTCCCT)

Ehd1-2

(TCCAGGGCCCACATGGTAGAAGGAGAGAGT)

Ehd1-3

(GCTCCGGTCTTGGACTTCACCAGCATTTAG)

Ehd3-212

(CAACAAGAGTGTCAGGAAACCTGAACTAAG)

Ehd3-213

(CTGGGAAACTGCAGAACATCAGGGAACAGC)

Ehd3-215

(ATGAGGGACTCAAGGGGCAAGTCCTGGAGG)

Ehd4-28

(ACGCGTCGACACTAGCCCTTTGCATCTGTCAGTTA)

Ehd4-32

(ACGCGTCGACACCCAAACAAAGAGATGTTTAGTGC)

Ehd4-33

(GCCTGTGGCTGAAATATCATTAGT)

Ehd4-35

(ATTTGCGGCCGCGTCATTTGCAGGTGTCTAGTGAGTT)

Ehd4-90

(GGGTTATTGAATATGATCGGAATTGGGCTGCAGG)

CreF

(GCGGTCTGGCAGTAAAAACTATC)

CreR

(GTGAAACAGCATTGCTGTCACTT)
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5.4 Western blotting
Lymphoid tissues or isolated cells were lysed in ice-cold Triton X-100 lysis buffer (0.5% Triton
X-100, 50 mM Tris pH 7.5, 150 mM NaCl, 1 mM PMSF, 10 mM NaF, 1 mM VO4) or with
RIPA lysis buffer (same as Triton X-100 lysis buffer with an increase of Triton X-100 to 1% and
an addition of 5 mM EDTA, 1 mM EGTA, 1% SDS, and 0.5% sodium deoxycholate). Lysates
were vortexed, centrifuged at 13,000 rpm for 30 minutes at 4o C either immediately or after
overnight rocking in the cold room, and supernatants were collected. Protein lysates were
quantified using the bicinchoninic acid (BCA) assay. 40 μg aliquots of lysate protein per sample
were resolved by SDS/PAGE and transferred to PVDF membranes (from Immobilon-P, cat #
IPVH00010). In certain experiments, lysates from equal numbers of cells were resolved by
SDS/PAGE. The membranes were blocked in TBS/5% BSA, incubated with the appropriate
primary antibodies diluted in TBS-0.1% Tween 20 for 1 hr, washed in TBS-0.1% Tween (3x for
5 minutes each) followed by a 45-min incubation with HRP-conjugated secondary antibody in the
same buffer. The membrane was then washed in TBS-0.1% Tween (3x for 5 minutes each) and
ECL-based detection was performed.
5.5 CD4+T-cell isolation
To isolate primary CD4+ T-cells, a negative selection protocol was performed as described
(Kamala, 2008) using magnetic beads (Invitrogen Biotin binder kit cat. # 11533D) and
biotinylated antibodies (Biolegend), and purity was established to be 91-95% based on flow
cytometry.
5.6 Fluorescence Activated Cell Sorting (FACS)
T-cells were incubated on ice in the dark for 15 to 30 min (depending on the experiment) with
appropriate conjugated antibodies at the manufacturer’s recommended dilution in FACS buffer
(0.1% BSA in PBS). Cells were pelleted, washed twice, and suspended in 400 µl of cold FACS
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buffer. In other cases, cells were fixed with 4% cold PFA for 15 min at room temperature after
staining; then washed and suspended in 400 µl of cold FACS buffer. Cells were protected from
light until analyses using either the LSR II Green or LSR II cytometer (BD Bioscience). FACS
data were analyzed using DIVA (BD FACSDIVA TM Software), FlowJo (FLOWJO, LLC Data
Analysis Software, Ashland, OR) and ModFit LT software (Verity Software House, Topsham,
ME).
5.7 CFSE and CellTrace VioleT-cell proliferation dye dilution assay
Spleen cells (5x106cells/ml) from CD4-Cre; 2D2Tcr; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl mice and
control (2D2Tcr; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl) mice were stained with CFSE or CellTrace Violet
according to the manufacturer’s instructions. Cells were treated with 50 µg/ml of MOG35-55
peptide for 72 hrs. On the indicated day, cells were stained with FITC-CD4 before analysis.
Dilution of CFSE or CellTrace Violet fluorescence as an indicator of cell division was assessed
via FACS analysis. Data were analyzed using FlowJo and ModFit LT software. ModFit LT
software was also used to determine the Proliferation Index (PI). In some instances, the cells were
not stained with the proliferation dye, but were stained with anti- AnnexinV and Propidium
Iodide staining solution after 72 hrs of stimulation and analyzed by FACS for cell death analysis.
5.8 3H-thymidine incorporation assay and T-cell expansion
Spleen cells (5x105 cells/well) from CD4-Cre; 2D2Tcr; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl or control
(2D2Tcr; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl) mice were seeded in 96-well U-bottom plates in 100 µl
medium in the presence of varying concentrations of MOG35-55 peptide for 72 hrs. Cells were
pulsed with 1 µCi of 3H-thymidine per well for the last 6 hrs of incubation, harvested onto filter
disks and the radioactivity (counts per minute) counted using a scintillation counter (Packard).
For T-cell expansion, spleen cells or LN cells from CD4-Cre; 2D2Tcr; EHD1fl/fl; EHD3fl/fl;
EHD4fl/fl mice and control (2D2Tcr; EHD1fl/fl; EHD3fl/fl; EHD4fl/fl) mice were stimulated with 10-
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20 µg/ml of MOG 35-55 peptide and T-cells were expanded in the presence of 30 U/ml IL-2 for 7-8
more days (in fresh IL-2-containing media changed every two days after three days of
stimulation).

5.9 In vitro deletion of EHD proteins (EHD1, 3 and 4)
Spleen cells or LN cells from EHD1fl/fl; EHD3fl/fl; EHD4fl/fl; CreERT2; 2D2Tcr mice were prestimulated with either the MOG peptide or with anti-CD3 and anti-CD28 for three to four days in
the presence (+) or absence (-) of 4-hydroxytamoxifen (4-OHT) (200 nM-300 nM) for deletion of
EHD 1, 3 and 4. Cells were washed in PBS, stained with CFSE, and were re-stimulated for
proliferation as previously described.

5.10 ELISA

Isolated spleen cells (5x105 cells/well) were cultured in 96-well U-bottom plates in the presence
of 10 µg/ml of MOG35-55 peptide at 37oC for indicated time points. IL-2 secretion was measured
in culture supernatants using an ELISA kit according to the manufacturer’s instructions.

5.11 Cell surface TCR internalization assay

Internalization of cell surface pool of TCR-CD3 was assessed as previously described (Carrasco,
Navarro, & Toribio, 2003; H. Liu, Rhodes, Wiest, & Vignali, 2000) with modifications. Briefly,
freshly isolated LN cells at 5x106 cells/ml in 96-well U-bottom plates (in triplicates) were
incubated in the presence of 10

g/ml BFA at 37oC for the indicated times to allow the surface

TCR to internalize in the absence of newly synthesized TCR transport to the cell surface. At each
time point, cells were transferred into ice and subsequently stained with PE-conjugated anti-CD3
followed by FACS analysis to quantify the surface TCR levels remaining at each time point. The
extent of the TCR remaining at the cell surface was calculated by expressing the median
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fluorescent intensity (MFI) of PE-anti-CD3 staining at each time point relative to time 0, which
was set as 100%.

5.12 Analysis of TCR recycling

The recycling of pre-existing intracellular pools of TCR-CD3 was carried out by adapting a
previously described protocol (Dietrich et al., 2002). Briefly, the accessibility of the cell surface
CD3 on freshly isolated LN cells (at 5x106 cells/ml in 96-well U-bottom plates in triplicates) was
blocked by staining with a predetermined saturating concentration of unconjugated anti-CD3 at
4oC for 30 min. The cells were extensively washed and incubated at 37oC. At the indicated times,
the cells were transferred to 4oC and stained with a PE-conjugated version of the same anti-CD3
antibody that was used to block the staining of the initial cell surface cohort of CD3. The MFI of
PE-anti-CD3 cell surface FACS staining was used as a measure of the recycling of intracellular
TCR-CD3. Recycling of cell surface TCR-CD3 pool following internalization was assayed by a
modified protocol (Osborne, Piotrowski, Dick, Zhang, & Billadeau, 2015; Sullivan & Coscoy,
2008). Freshly isolated LN cells were first stained with PE-conjugated anti-CD3 for 30 min on
ice. After extensive washes, the cells were incubated at 37oC for 30 min (in complete RPMI) to
allow the antibody-labelled TCR-CD3 to undergo internalization. The cells were then subjected
to an acid wash to strip any remaining antibody bound to CD3 on T-cell surface. The cells were
washed in cold FACS buffer and re-suspended in complete RPMI followed by incubation at 37oC
for the indicated times to allow recycling of the labelled internalized pool of TCR-CD3 back to
the cell surface. The cells were spun down, acid washed, and re-suspended in FACS buffer for
FACS analysis to determine the remaining intracellular fraction of the internalized TCR-CD3.
The percentage of TCR-CD3 recycling was calculated from the equation ((T0-Tx)/T0) x 100, where
T0 is the MFI of cells incubated for 0 min before the second acid wash, while Tx is the MFI of
cells subjected to a second acid wash after incubation for the indicated times.
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5.13 Confocal Microscopy
Lymph node T-cells were expanded as described under T-cell expansion. A total of 5 x106
expanded T-cells in complete RPMI medium were plated onto Poly-L-lysine-coated coverslips
placed in 24-well plates and allowed to attach at 37oC for 10 min. Cells on coverslips were fixed
in 4% ice-cold PFA for 20 min and then incubated with 0.1M glycine (in PBB) for 3 min at room
temperature. After washing, the cells were incubated with the blocking plus permeabilization
buffer (2% BSA +0.1% Triton in PBS) for 30 min at room temperature. Cells were stained with
anti-Lamp-1 and anti-CD3 primary antibodies overnight a 4oC. After three washes, the cells were
stained with secondary anti-rat (for Lamp-1) and anti-Armenian hamster antibodies for 45 min at
room temperature. After washes, the cells were mounted with VECTASHIELD Hard Set
mounting medium with DAPI (Vector laboratories, Cat # H-1500). Images were acquired at room
temperature using a ZEISS ELYRA S.1 and superresolution structured illumination (SR-SIM).
The sCMOS camera mounted on side port was used. Objective lenses: Plan-APOCHROMAT
63x/1.40 Oil DIC. For resolution: lateral resolution (XY): 120 nm, axial resolution (Z): 300 nm
(typical experimental FWHM values with objective lens Plan-APOCHROMAT 63x/1.40 Oil
DIC, subresolution beads of 40 nm diameter and excitation at 488 nm). Merged fluorescence
pictures were generated and analyzed using ZEN ®2012 software from Carl Zeiss.

5.14 Induction and monitoring of Experimental Autoimmune Encephalomyelitis (EAE)
fl/fl

fl/fl

Six to eight week old female CD4-Cre; 2D2Tcr; EHD1 ; EHD3 ; EHD4
fl/fl

fl/fl

fl/fl

or control (2D2Tcr;

fl/fl

EHD1 ; EHD3 ; EHD4 ) mice were subcutaneously immunized in the flank with 200 µg of
MOG35-55 peptide emulsified (1:1) in complete Freund’s adjuvant (CFA) containing 0.5 mg heatkilled Mycobacterium tuberculosis H37RA in a total of 200 µl emulsion per mouse, together with
an intraperitoneal injection of pertussis toxin (200 ng/mouse) in 200 µl PBS followed by a second
dose of pertussis toxin two days later. Mice were monitored daily and scored for clinical signs of
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EAE on a scale of 0-5 whereby 0 = no disease; 1 = decreased tail tone; 2 = hind limb weakness or
partial paralysis; 3 = complete hind limb paralysis; 4 = front and hind limb paralysis; and 5 =
moribund state or dead (Bettelli et al., 2003). Composite scores of each cohort were used to
determine statistical significance.

5.15 Statistics
An unpaired student’s t test was used to calculate the p-values. Data are presented as
mean ± SEM and p<0.05 served as the threshold for statistical significance.
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CHAPTER 3: REQUIREMENT OF EHD PROTEIN FAMILY FOR T CELL
FUNCTION
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3.6. Introductions
Understanding of the mechanisms that underlie proper T-cell function is of great interest
in basic immunology and immunopathology. T-cell activation requires recognition of an antigenic
peptide bound to MHC proteins on antigen presenting cells (APC) by the T-cell antigen receptor
(TCR) and downstream signaling mediated by cytoplasmic regions of the TCR-CD3 complex.
Effective generation of an immune response requires concurrent engagement of and signaling
through co-stimulatory proteins (e.g., CD28) on T cells by their cognate ligands on the APC
surface (Huppa et al., 2003). Therefore, the mechanisms that ensure optimal levels of the TCR
and accessory receptors on the T-cell surface prior to antigen stimulation are fundamentally
critical to generating an effective immune response. However, mechanisms that regulate the
surface pool of TCR and its accessory receptors have been primarily investigated in the context of
T-cell activation. During T-cell activation, TCR signaling elicited by the APC-presented antigen,
together with co-stimulatory signals, leads to spatial reorganization of the TCR and accessory
receptors, such as CD28 and lymphocyte function-associated 1 (LFA-1), to form an area of
intimate contact with APCs, the immunological synapse (IS) (Hashimoto-Tane et al., 2010; Jo et
al., 2010). The endocytic pathways supply the IS with newly synthesized and recycled receptors
to replenish those that are targeted to the lysosome for degradation (Das et al., 2004; Lee et al.,
2003; Valitutti, Muller, Salio, & Lanzavecchia, 1997) .
Cells use clathrin-dependent as well as clathrin-independent pathways to internalize
surface receptors into early (EE)/sorting endosome compartments, from where they traffic to late
endosome/multi-vesicular bodies and lysosomes for degradation, or recycle back to the cell
surface. To go back to the cell surface, receptors either through a Rab4+ fast recycling endosome
(RE) (directly to the plasma membrane) or through a slow recycling route via the Rab11+ RE
(Gould & Lippincott-Schwartz, 2009; Naslavsky & Caplan, 2011). This sorting process is known
to be regulated by Rab family of small GTPases and their interacting partners (Walseng et al.,
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2008). T-cell receptors such as TCR-CD3 (Huppa et al., 2003), CD28 (Cefai et al., 1998) and
LFA-1 (Fabbri et al., 2005; Stanley et al., 2012) are known to be internalized and recycled to the
IS during T-cell activation. Internalized TCR-CD3 traverses the Rab5+ EE, followed by transport
through Rab4+ and Rab11+ endosomes, indicating the involvement of both fast and slow recycling
pathways (Kumar, Kremer, Dominguez, Tadi, & Hedin, 2011; H. Liu et al., 2000). Naïve and
resting T-cells constitutively internalize and recycle their surface receptors and the balance of
these processes dictates their pre-stimulation surface levels and hence the levels of T-cell
activation (H. Liu et al., 2000). Yet, the mechanisms of constitutive basal traffic of TCR-CD3 are
not fully understood.
Recently, a new family of endocytic regulators, the EPS15 Homology Domain-containing
proteins (EHD1-4), has been identified. These proteins exhibit a conserved domain architecture
with helical regions near the N-terminus and the middle of the protein surrounding an ATPbinding G-domain that can hydrolyze ATP slowly, and a C-terminal EH domain that binds to
proteins with asparagine-proline-phenylalanine (NPF)-containing or related tripeptide motifs as a
major mechanism of protein-protein interactions (Mintz et al., 1999; Pohl et al., 2000). Structural
studies of EHD2 reveal that the helical regions form a curved membrane lipid-binding interface,
and that the ATPase domain folds similar to the GTPase domain of dynamin and mediates the
formation of stable dimers (Daumke et al., 2007). Other structural findings support a model that
dimeric EHDs organize into oligomeric rings around curved membrane structures and function in
membrane tubulation and vesiculation (Blume, Halbach, Behrendt, Paulsson, & Plomann, 2007;
Daumke et al., 2007; Ioannou & Marat, 2012; Jakobsson et al., 2011; Shah et al., 2014).
Consistent with these biochemical observations, cell biological studies have shown that EHD
proteins regulate recycling of several surface receptors that traffic through clathrin-dependent or
clathrin-independent pathways, including transferrin receptor, MHC class I, β1 integrin, AMPA
receptors, insulin-like growth factor 1 receptor (IGF1R), insulin-responsive glucose transporter 4
(GLUT4), and others (Caplan et al., 2002; George et al., 2007; Grant et al., 2001; Guilherme et
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al., 2004; Jovic et al., 2007; Lasiecka et al., 2010; Lin et al., 2001; Naslavsky & Caplan, 2011;
Rapaport et al., 2006). However, the physiological relevance of the many in vitro assigned roles
of EHD proteins remains to be defined.
We used gene targeting in mice to reveal the in vivo functional roles of EHD proteins and
cell surface receptors whose traffic is regulated by EHDs (Curran et al., 2014; Cypher et al.,
2016; Demonbreun et al., 2015; Doherty et al., 2008; Gudmundsson et al., 2010; Posey et al.,
2011; Posey et al., 2014). For example, EHD1 KO mice exhibit strain-dependent phenotypes
varying degrees of embryonic lethality, male infertility, ocular developmental defects, and neural
tube closure defects due to impairment of ciliogenesis and SHH signaling (Arya et al., 2015;
Bhattacharyya et al., 2016).
To date, any roles of EHD-family proteins in TCR traffic or T-cell function are unknown.
Given their importance in the regulation of a variety of other cell surface receptors and the
consequences of deleting their genes, singly or in combination, on organ/cell function in vivo, we
hypothesized that EHD proteins could play an important functional role in T cells by regulating
receptor traffic. Consistent with such a hypothesis, EHD proteins have been shown to interact
with Rab effectors, such as Rabenosyn-5, a dual Rab4 and Rab5 effector in the early endosome
(Naslavsky, Boehm, Backlund, & Caplan, 2004), and Rab11 effector, Rab11-FP2, which
regulates the exit of vesicles from the recycling endosome back to the plasma membrane
(Naslavsky et al., 2006). Moreover, EHD proteins (EHD1, EHD3, and EHD4) were shown to
interact with SNARE complex proteins such as SNAP-25, SNAP29 (Lu et al., 2015; RotemYehudar, Galperin, & Horowitz, 2001), Syndapin I and II (Braun et al., 2005; Giridharan et al.,
2013; Naslavsky & Caplan, 2011), and other proteins in non-T-cell systems. EHD proteins have
been shown to localize in endosomes positive for Rab5, Rab4, Rab8, Rab11 or Rab35 (Caplan et
al., 2002; Lasiecka et al., 2010; Sharma et al., 2008; Walseng et al., 2008), compartments that ae
implicated in TCR traffic (Finetti et al., 2014; Finetti et al., 2015; Patino-Lopez et al., 2008).
Thus, we posited that EHD proteins could play an important functional role in T cells.
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We found that EHD 1, 3 and 4 are expressed in lymphoid tissues and in purified CD4+ T
cells. Accordingly, we generated myelin oligodendrocyte glycoprotein (MOG)-specific TCR
transgene (2D2-TCR Tg)-bearing mice in which floxed EHD 1, 3 and 4 were deleted using a
CD4-Cre transgene. In vitro, CD4+ T-cells of EHD1fl/fl; EHD3fl/fl; EHD4fl/fl; Cd4-cre; 2D2Tcr
mice (EHD1/3/4 knockout) exhibit reduced antigen-driven cell proliferation and IL-2 secretion.
In vivo, these mice exhibit a reduced severity of experimental autoimmune encephalomyelitis
(EAE) elicited by immunization with the MOG peptide. We show that surface levels of TCR,
CD28, and LFA-1 are reduced and TCR recycling is impaired in CD4+ T cells of mice with a
CD4-Cre-mediated EHD1/3/4 knockout. Therefore, our studies reveal a novel role of the EHD
family of endocytic recycling proteins in the surface display of TCR in unstimulated T cells that
contributes to their positive functional role in antigen-induced T-cell activation and
immunopathology.
3.7. Results:

7.1 Multiple EHD Family Members are Expressed in Lymphoid Organs and Purified CD4+
T-cells.

Our previous Western blotting studies of EHD protein expression in the mouse thymus
and spleen (George et al., 2010; George et al., 2011; Rainey et al., 2010), which we extended here
to lymph nodes (LN) (Fig. 1A), showed that multiple EHD family members are expressed, albeit
unequally, in lymphoid organs. This suggested that multiple EHD family members are likely to
be expressed in individual immune cell types, consistent with our recent findings that bone
marrow-derived macrophages (BMDMs) express both EHD1 and EHD4 (Cypher et al., 2016).
With the focus of this study on functional analyses in the context of CD4+ T-cells, our additional
analyses showed that EHD 1, 3 and 4 are expressed in primary murine CD4+ T-cells (Fig. 1B)
while EHD2 protein was undetectable to barely detectable. Analyses of mRNA expression
databases (ImmGen and BioGPS) further support this expression pattern. Notably, western

54
blotting of purified LN T-cells at various time points of anti-CD3/CD28 stimulation showed that
levels of EHD proteins vary as a function of CD4+ T-cell activation, with a time-dependent
increase in EHD 1 and 4 levels and a reduction in EHD3 levels (Fig. 2). These findings suggested
that EHD proteins may play important roles in T-cell function.

Our previous knockout studies have revealed relatively unique as well as redundant
functional roles of EHD proteins, with the knockout of EHD1 alone producing by far the most
obvious developmental and adult organ functional aberrations, depending on the strain
background (Arya et al., 2015; Bhattacharyya et al., 2016; Rainey et al., 2010; Rapaport et al.,
2006). We assessed lymphoid organs of EHD1-/- mice for any immune defects and we saw that
globally, their lymphoid tissues maintained normal structural architecture compare to those from
the Wt mice (Fig. 3A). Therefore, we assessed whether EHD1 deficiency had any impact on Tcell activation. Notably, the initial analysis of EHD1-/- splenic T-cells did not reveal any
detectable abnormality in anti-CD3/CD28 induced cell proliferation (Fig. 3B). These findings
supported a redundant functional role of EHD proteins, at least in the context of T-cell
proliferation. Consistent with this, an increase in EHD4 levels was noted in LN from EHD1-/mice (Fig. 3C). In addition, we also noted an increase in the levels of both EHD1 and EHD4 in
spleen and lymph nodes of EHD3-/- mice (Fig. 3D). Initial analysis of EHD4-/- T-cells shows that
they proliferate less than CD4+ T cells from control mice (Fig. 3E, 3F). We also noted that the
deletion of EHD4 in lymph node cells did not cause an increase in the level of EHD1 and
EHD3.Given the likelihood of redundant EHD function, we used a combinatorial knockout
strategy to further explore their role in T-cells.
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7.2 CD4-Cre-Mediated Conditional Deletion of EHD1/3/4 in T-cells Leads to a Reduced
Proportion of CD4+ T-cells in Secondary Lymphoid Tissues.

Given the likelihood of redundant EHD function, we generated mice with a CD4-Credepepndent, T-cell directed, conditional deletion of floxed Ehd1, Ehd3, and Ehd4 genes. To
examine the impact of EHD 1/3/4 deletions in T-cells in the context of antigen-specific responses,
we also incorporated the MOG peptide-specific 2D2-Tcr transgene (Bettelli et al., 2003) into our
conditional knockout model (referred to as CD4-Cre+ mice) (Fig. 4). Littermates without a CD4Cre transgene were used as controls (referred to as CD4-Cre- mice). Western blot analysis of
CD4+ T-cells isolated from the 2D2-Tcr transgenic mice showed that the presence of the
transgenic TCR by itself did not have any detectable impact on the levels of EHD proteins (Fig.
5A). CD4-Cre+ mice were developmentally indistinguishable from CD4-Cre- mice and no gross
phenotypic changes were seen in adult mice. We check the specificity of the transgenic receptor
to the antigen and showed that they are specific to the MOG peptide (Fig. 5B, 5C, & 5D). Tail
PCR and Western blot analysis confirmed the CD4-dependent deletion of EHD1/3/4 (Fig. 5E and
Fig. 6A).
Next, to examine whether EHD1/3/4 deletion impacted T-cell development, we isolated
single cells from lymphoid organs of 4-week-old mice and analyzed these for changes in T-cell
numbers using cell counting combined with FACS. We found that total numbers of thymocytes,
splenocytes, and LN cells were comparable in mice from both groups (Fig. 6B). Similarly,
comparable cell numbers were observed when spleens of older (6-8 weeks old) mice of the two
genotypes were analyzed (Fig. 6C). We carried out FACS analyses on the live/B220- T-cell
population, and assessed the proportion of cells at various developmental stages based on staining
with antibodies against CD4, CD8, CD25 and CD44 (Dashtsoodol, Watarai, Sakata, & Taniguchi,
2008; G. Liu et al., 2014; Wang et al., 2009). Single positive thymocytes in 2D2-Tcr Tg mice are
known to be skewed toward the CD4+ T-cell compartment; this is also seen in spleen and LN
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(Bettelli et al., 2003) (Fig. 5F). CD4-Cre-mediated deletion of EHD 1/3/4 did not affect the
relative percentages or total cell numbers within various thymic developmental stages when
analyzed in 4-week-old mice (Fig. 6D and 6E).
In contrast, CD4-Cre-mediated EHD1/3/4 deletion led to a decrease in the percentage of
T-cells in the periphery. This phenotype was seen in both the spleen and LN (Fig. 6F, 6G).
However, the absolute number of CD4+ T-cells in these organs did not differ significantly
between CD4-Cre positive and control mice. In addition, an apparent increase in peripheral B cell
numbers and their percentages were seen (Fig. 6F, 6G); the basis of this phenotype is unknown
but is likely to reflect altered T-cell- B-cell interactions due to T-cell deficiency of EHD1/3/4. We
also saw a decrease in the percentage of CD8+ T-cells in spleens of CD4-Cre positive mice, but
this did not reflect an increase in CD8+ T-cell numbers in these same organs. From these results,
we conclude that expression of EHD proteins is dispensable during thymic T-cell development,
but may play a role in peripheral T-cell function.

7.3 Expression of EHD Proteins is Required for Optimal Antigen-Induced T-cell Activation
in vitro and for EAE in vivo.

Incorporation of a MOG antigen-specific TC transgene in our EHD1/3/4 deletion models
allowed analyses of CD4+ T-cell response to a specific antigen, both in vitro and in vivo, the latter
in the context of the development of EAE. We asked whether the mature T-cells in these mice
exhibit any functional deficits. Initial experiments, using spleen cells from the parental 2D2-TCR
transgenic and control mice with MOG or ovalbumin peptides, established the optimal
concentrations of MOG peptide to induce T-cell proliferation (not shown). Analysis of CD4+ Tcells from spleen using the CellTrace Violet stain and 3H-thymidine incorporation showed a
significant decrease in proliferation of T-cells from CD4-Cre+ mice compared to control CD4Cre- (Fig. 7A, 7B). Visualization of progressive cell divisions using ModFit LT software, showed
that while CD4-Cre+ and CD4-Cre- CD4+ T-cells progress through a comparable number of
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divisions, EHD1/3/4-null T-cells exhibit a significant underrepresentation at late divisions and an
increased proportion of cells at earlier divisions (Fig. 7A). The EHD1/3/4-null T-cells also
exhibited a significantly lower overall proliferation index (Fig. 7A), further supporting the
conclusion that these cells proliferate slower than the control T-cells. To exclude the possibility
that the apparent decrease in the number of EHD1/3/4-null T-cells at late stages of proliferation
might be due to their apoptosis, we stimulated the CD4+ T-cells as previously described and
stained these with PI and anti-Annexin V followed by FACS analysis. We observed no increase
in the percentage of apoptotic cells in antigen-stimulated CD4+ T-cells isolated from CD4-Cre+
compared to CD4-Cre- (control) mice (Fig. 7C). Thus, the mature peripheral CD4+ T-cells of
CD4-Cre- exhibit a marked defect in the specific antigen-induced cell proliferation in vitro.

To assess whether the impact of EHD1/3/4 protein deficiency on CD4+ T-cell
proliferation reflects their abnormal development or an actual importance in the events associated
with T-cell activation, we used T-cells from 2D2-TCR Tg-bearing mice carrying a tamoxifeninducible ERT-Cre that allows in vitro deletion of EHD1/3/4. EHD1/3/4 deletions in vitro led to
a significant decrease in antigen-induced proliferation compared to their control T-cells (Fig. 7D,
7E, 7F). These results support a T-cell intrinsic positive role of EHD proteins in sustaining
antigen-driven T-cell responses in mature peripheral T-cells.

Among the cytokines that initiate antigen-activated T-cells into proliferation is the
activation-induced secretion of IL-2 and the induced expression of the corresponding receptor on
the T-cell surface (Boyman & Sprent, 2012; Malek, Yu, Scibelli, Lichtenheld, & Codias, 2001).
Therefore, we assessed the impact of EHD1/3/4 deletions on IL-2 secretion. We observed a
significantly lower level of antigen-induced IL-2 secretion by EHD1/3/4-null CD4+ T-cells (Fig.
7G) with a difference detectable at the earliest time point (12 hrs) analyzed, making it unlikely
that the reduction is due to a smaller pool of T-cells caused by reduced proliferation. The
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significant reduction in IL-2 secretion is likely to represent one mechanism for the defective Tcell proliferation upon deletion of EHD1/3/4.

The impact of EHD1/3/4 deficiencies was not restricted to in vitro T-cell responses alone.
Using immunization with the MOG35-55, we were able to test the impact of EHD1/3/4 deficiencies
on the development of EAE in vivo. We immunized cohorts of control (CD4-Cre-) vs.
experimental (CD4-Cre+) mice with MOG35-55 and assessed onset and severity of EAE over time.
Interestingly, while no significant difference in the disease onset was seen, EHD1/3/4 –null group
showed a decrease in the disease severity compared to control littermates (Fig. 7H). These results
further support our conclusion that the expression of EHD proteins is important for full CD4+ Tcell responses to antigen. Altogether, these in vitro and in vivo analyses established, for the first
time, that EHD proteins play an important positive role in antigen-driven T-cell activation and
immune response.

7.4 EHD Proteins Regulate the Traffic of the TCR-CD3 Complex to the Cell Surface.

At a cellular level, EHD proteins have been characterized as regulators of the endocytic
traffic of cell surface receptors as mentioned in the introduction. Endocytic traffic of these
receptors is key to their targeting to the immunological synapse (Andres et al., 2004; Cefai et al.,
1998; Fabbri et al., 2005; Huppa et al., 2003; H. Liu et al., 2000; Qureshi et al., 2012; Stanley et
al., 2012; Valk, Rudd, & Schneider, 2008; von Essen et al., 2004). To assess whether EHD
proteins may indeed regulate the traffic of TCR-CD3 or the accessory receptors, we first
examined the cell surface levels of TCR-CD3, CD28, and LFA-1 by FACS analysis of
unstimulated T cells. As assessed by comparing the MFI values, T-cells from CD4-Cre+ mice
expressed significantly lower levels of TCR-CD3 on the cell surface compared to T-cells from
control mice (Fig. 8A). These analyses also showed that in vitro activated CD4+ T-cells from
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CD4-Cre+ mice express lower levels of TCR-CD3, CD28, CD25, CTLA-4 and LFA-1 compared
to those from control mice (Fig. 8A).

Since the TCR-CD3 complex is the primary determinant of antigen-specific T-cell
activation and subsequent responses, we focused on the TCR for further analyses. We examined
the kinetics of TCR-CD3 internalization and recycling in unstimulated CD4+ T-cells. Analysis of
TCR-CD3 internalization using FACS showed that there was not significant difference in
internalization of TCR in EHD1/3/4 -null T-cells compared to control T-cells (Fig. 8B). Next, we
analyzed recycling to the cell surface of the pre-existing intracellular pool of TCR/CD3. For this
purpose, anti-CD3Ɛ antibody recognition epitope on the pre-existing surface TCR-CD3 was
blocked with an un-conjugated antibody and the appearance of intracellular TCR-CD3 on the cell
surface at various time points was monitored by staining with a conjugated anti-CD3Ɛ. These
analyses showed that EHD1/3/4 -null CD4+ T-cells exhibit a significantly reduced recycling of
pre-existing intracellular TCR-CD3 to the cell surface at all time points analyzed compared to
control T-cells (Fig. 8C). Next, we assessed the recycling of the pre-existing cell surface pool of
TCR-CD3 by pre-labelling it with a PE-conjugated anti-CD3 and allowing it to internalize. After
acid wash (to strip any remaining antibody bound to TCR-CD3 on T-cell surface), the
internalized PE-labeled TCR-CD3 was allowed to reappear at the cell surface and re-stripped to
remove the labeled antibody. Even under these assay conditions, we observed a significant
decrease in the recycling of TCR-CD3 in EHD1/3/4 -null CD4+ T-cells compared to control cells
(Fig. 8D). Overall, these results show a key requirement for EHD 1, 3 and 4 in basal recycling of
TCR-CD3 from intracellular endocytic recycling compartments back to the cell surface.
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7.5 Deletion of EHD1, 3 and 4 Promotes the Lysosomal Degradation of TCR-CD3.

Given the impairment of the endocytic recycling together with the reduced steady-state
surface TCR-CD3 levels in freshly isolated EHD1/3/4-null T cells (Fig. 8A, 8C, 8D), we
considered the possibility that the pool of TCR-CD3 that is retained in intracellular compartments
may be aberrantly targeted for lysosomal degradation. To address this, EHD1/3/4-null T cells
(from CD4-Cre-mediated and 4OHT-induced ERT-Cre deletion) were examined by western
blotting for total levels of CD3Ɛ. In both cases, we found that deletion of EHD proteins led to a
significant decrease in the total levels of CD3Ɛ (Fig. 9A, 9B). Given our findings with the CSF-1
receptor in macrophages (Cypher et al., 2016), we hypothesized that this reduction was likely due
to lysosomal targeting and degradation. To test this hypothesis, we treated the EHD1/3/4-null Tcells with or without bafilomycin-A1, an inhibitor of lysosomal degradation, for 4 h and analyzed
the impact on total CD3Ɛ levels using western blotting and confocal (Fig. 10). Western blotting
of cells treated with Bafilomycin A1 for 4 h showed a recovery of the CD3Ɛ protein level in
EHD1/3/4 -null T cells with levels in treated cells comparable to those in control cells (Fig. 10A,
10B). We performed confocal imaging of control and EHD1/3/4 -null T cells incubated with or
without bafilomycin-A1. Some co-localization was seen in Bafilomycin A1-treated control T
cells (Fig. 10C, upper panel). Notably, significantly more lysosome-localized CD3Ɛ was seen in
EHD1/3/4 -null cells treated with bafilomycin-A1 (Fig. 10C, lower panel and Fig 10D right).
However, relatively low CD3Ɛ staining was co-localized with the lysosomal marker LAMP-1 in
untreated cells (Fig. 10D left). These results support the conclusion that expression of EHD1/3/4
is required for efficient transport of TCR-CD3 from endosomal compartments back to the cell
surface and to prevent its aberrant traffic into lysosomes.
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3. 8. Discussions

Cellular studies have identified members of the EHD protein family as key new
regulatory elements of endocytic trafficking of several cell surface receptors, but their
physiological functions remain relatively unexplored and their roles in the immune system
unknown. Here, we investigate the role of EHD proteins in the context of antigen-specific CD4+
T-cells in vitro and in vivo. Our genetic studies, ablating genes encoding three members of the
EHD protein family (EHD 1, 3 and 4) by CD4+ T-cells in the context of MOG transgenic TCR,
demonstrate for the first time, an important, positive role of EHD proteins in antigen-specific Tcell activation in vitro and an autoimmune response in vivo. Mechanistically, we show that EHD
proteins are required for basal recycling of TCR-CD3 from intracellular endocytic pools to the
cell surface, thereby determining the subsequent level of T-cell activation. Combined with our
recent study demonstrating a key positive role of EHD1 in the transport of newly synthesized
CSF-1R from the Golgi to the cell surface of BMDMs (Cypher et al., 2016) and previous cell
biological findings that EHD1 facilitates MHC class I recycling from the endocytic recycling
compartment to the cell surface in a cell line system (Caplan et al., 2002), our results strongly
support the likelihood that EHD proteins play critical and potentially diverse roles in the immune
system.

Analysis of thymic T-cell development did not reveal any significant alterations in total
cellularity, T-cell subsets or relative proportions of T-cells at different stages in mice with a CD4Cre mediated deletion of EHD1/3/4, indicating that EHD proteins are largely dispensable for
thymic development beyond the CD4/8 double-positive stage. Whether this might reflect any role
of the remaining EHD family member, EHD2, remains a possibility that will require future
studies. It is also possible that EHD proteins are important at earlier stages of thymic
development and future use of other Cre elements active at these stages will be needed to address
this possibility. Also, since our analyses, of which the primary purpose was not to probe thymic
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development, were carried out in the context of a pre-rearranged TCR transgene, this could have
masked a potential developmental role of EHD proteins in the context of a normally diverse TCR
repertoire.

In contrast to the relatively unperturbed thymic development, CD4-Cre-mediated
EHD1/3/4 deletion led to a decrease in the percentage of T cells in the periphery. This phenotype
was seen in secondary lymphoid tissues, including the lymph nodes and the spleen. These results
suggested that EHD proteins may play a more important role in mature peripheral T cells. The
precise basis for this phenotype remains unclear but lower functional responses to TCR
engagement, as seen in ex vivo analyses (discussed below), could play a role since TCR signals
are important in peripheral T-cell maintenance (Cantrell, 1996; Daniels & Teixeiro, 2015; Surh &
Sprent, 2008). In addition, an apparent increase in the peripheral B cell numbers and their
percentages was seen; the basis of this phenotype is unknown but is likely to reflect altered Tcell- B-cell interactions due to T-cell deficiency of EHD1/3/4.

The in vitro analyses of T cells from the CD4-Cre deletion model demonstrated
significantly defective antigen-elicited CD4+ T-cell proliferation and IL-2 cytokine secretion
responses upon EHD1/3/4 deletion. Similar results were observed using CD4+ T cells derived
from an alternate model where in vitro deletion of floxed EHD1, 3 and 4 genes was induced with
4-OHT to bypass any in vivo developmental abnormalities. These results support a T-cell intrinsic
positive role of EHD proteins in sustaining antigen-driven T-cell responses in mature peripheral T
cells, a role independent of any potential involvement of EHD proteins in events associated with
thymic T-cell development.

Coordination of multiple EAE-inducing T-cell functions, including their early activation,
expansion, migration to the brain across the blood/brain barrier, and effector functions to mediate
demyelination in the CNS are required for full disease induction (Furtado et al., 2008; O'Connor
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et al., 2008). Therefore, we analyzed the impact of EHD1/3/4 deficiencies on the onset and
progression of EAE. Since in vitro studies showed the T-cell proliferation and cytokine (IL-2)
secretion to be impaired upon EHD1/3/4 deficiencies, we expected to see a delayed onset and
reduced severity of EAE. While we saw no difference in the onset of disease, EHD1/3/4-null
mice showed a decrease in the disease severity compared to control littermates. Therefore,
further in vitro and in vivo studies using models developed here should help to comprehensively
reveal other aspects of T-cell function that also rely on EHD protein expression.

Given the reduced TCR-CD3 levels in the CD4+ T-cells of our EHD1/3/4 -null mouse
model prior to deliberate T-cell activation, our focus here has been on the role of EHD proteins in
basal (prior to antigenic stimulation) TCR-CD3 traffic, which has not been mechanistically
dissected in much detail. Therefore, further studies to identify partner proteins through which
EHDs regulate TCR traffic will be of great interest. Notably, endocytic trafficking pathways play
key roles during T-cell activation by orchestrating the polarized transport of TCR-CD3 and
signaling molecules such as Lck to maintain an active immunologic synapse, and Rab4- and
Rab11-positive endosomes are implicated in these processes (Soares et al., 2013).

Cell biological studies have linked EHD proteins to the regulation of traffic in Rab11+
recycling endosomes as well as compartments regulated by other Rabs. Thus, further studies to
examine the potential importance of EHD proteins in regulating endocytic traffic into and out of
the IS during T-cell activation will be of great interest. In this regard, we and others have recently
identified a key role of EHD proteins in primary cilia biogenesis (Bhattacharyya et al., 2016; Lu
et al., 2015) and recent studies have shown that the maintenance of IS in cilia-less T-cells
involves ciliogenesis-related proteins such as IFT20 which localize in the IS and are required for
recycling of TCR-CD3 (Finetti et al., 2009; Finetti et al., 2014; Finetti et al., 2015). Although
IFT20 KO under CD4-Cre led to only minor defects in T-cell development and collagen- induced
arthritis (an experimental model of rheumatoid arthritis), earlier deletion using Lck-Cre led to
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defective thymic development and T-cell function in vivo (Yuan, Garrett-Sinha, Sarkar, & Yang,
2014); the latter are partially similar to the phenotype of our EHD1/3/4 KO mice. Interestingly,
EHD1 and EHD3 were found to be important for the recruitment of transition zone proteins and
IFT20 during ciliary vesicle formation (Lu et al., 2015). Though our study has been done mainly
on freshly isolated and rested cells, it seems plausible that EHD proteins may also regulate the
traffic of TCR-CD3 in the IS to promote T-cell activation and subsequent responses.

Notably, the CD4-Cre mediated Wiskott-Aldrich syndrome protein and SCAR homolog
(WASH) deletion led to T-cell defects strongly resembling the phenotype of EHD1/3/4 deficiency
with minimal thymic developmental defects, reduced proliferation and cytokine production, a
decrease in the surface TCR-CD3 levels, increase in lysosomal degradation of TCR-CD3, and
reduced severity of EAE (Piotrowski, Gomez, Schoon, Mangalam, & Billadeau, 2013). WASH is
an Arp2/3 activator that localizes on distinct endosomal subdomains and functions in endosomal
trafficking (Jia et al., 2010). Given these phenotypic similarities of the two KO models and the
interaction of the WASH protein with retromer complex and the involvement of EHD proteins in
retromer-dependent transport (Gautreau, Oguievetskaia, & Ungermann, 2014; Seaman, 2012),
further exploration of a link between EHD proteins and WASH complex in regulating TCR-CD3
traffic will be of great interest.

Overall, studies presented here using genetic models and functional analyses, in vivo and
in vitro, reveal an important albeit redundant positive role of the newly described EHD family of
endocytic recycling regulatory proteins in T-cell function. Mechanistically, we show that EHD
proteins are required to facilitate basal recycling of TCR-CD3 from intracellular endocytic
compartments back to the cell surface to ensure the surface expression of optimal TCR-CD3
levels for subsequent antigen-driven T-cell activation. Future studies using the unique models
described here should add to our understanding of the importance of endocytic traffic in the
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control of TCR-CD3 and other receptors that regulate T-cell functions, as well as the roles of
these proteins in other cells in the innate and adaptive arms of the immune system.

3. 9. Figures

Figure 1: Expression of EHDs in Lymphoid Tissues and Isolated CD4+ T-cells. A) Lymphoid tissues
express all EHD proteins. One membrane (top) was probed with an antibody recognizing both EHD1 and
EHD4, and a second one (bottom) probed for EHD3 followed by re-probing for EHD2. β-Actin was used as
loading control. B) EHDs expression in T-cells. 40 µg of cell lysates from freshly isolated CD4 + T-cells
(from the spleen of a WT mouse) and Jurkat cells were loaded on a 10% SDS PAGE gel; cell lysate from
thymocytes was used as positive control. HSC70 was used as loading control. Membranes were probed for
EHD 1&4 (one antibody that detects both EHD 1and 4), and for EHD2. The EHD2 membrane was stripped
and re-probed for EHD3. (M=marker).
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Figure 2: EHD Proteins Show Differential Expression during T-cell Stimulation. A. CD4+ T-cells were
freshly isolated from C57Bl/6 mice and were incubated with (+) or without (-) ant-mouse CD3Ɛ/CD28 for
0, 24, and 48hrs for T-cell stimulation. Lysate of CD4+ T-cells from these time points and from the spleen
and thymus of the same mice were run on 10% SDS PAGE gel. The membrane was probed for EHD1,
EHD3, EHD4, and for β-Actin (loading control). B. Quantification of the western blots. Levels of EHD
proteins were normalized to β-Actin. This is a representative figure of two different experiments.
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Figure 3: Potential Redundant Functions of EHD Protein Family. A) EHD1 staining of the Lymph
-/-

+

node and spleen from EHD1 and Wt mice showing deletion of EHD1. B) Freshly isolated CD4 T-cells
-/-

from EHD1 and Wt littermate mice were stimulated with anti-CD3Ɛ and anti CD28 for 72hrs and were
subject to thymidine incorporation for the last 6 hrs of incubation. A representative figure of 3 independent
experiments is shown. C) EHD1, EHD3 and EHD4 protein expression in lymphoid organs from Wt and
EHD1-/- mice. Tissue lysate from these organs were loaded on a 10% SDS PAGE gel. D) Western blotting
showing upregulation of EHD1 and EHD4 in the spleen and lymph nodes of EHD3-/- compared to tissues
from Wt mice and upregulation of EHD4 in spleen and lymph nodes of EHD1

-/-

compared to control

tissues. Blots were probed for EHD1 and EHD4. E) Lymph nodes cells from Wt mice and EHD4 -/- mice
were stained with CFSE then stimulated with various concentration of anti-CD3 (1 µg/ml and 2.5 µg/ml)
for 3 days. Cells were stained with anti-CD4 to look at the proliferation profile of CD4 + T-cells. FACS
analysis of data modelled using ModFit software is shown. PI = proliferation index ± SEM of N = 3. F)
Western blotting of lymph nodes from Wt and EHD4-/- mice showing deletion of EHD4.
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Figure 4: Generation of the TgTCR; CD4-Cre; EHD (1, 3, 4) flox/flox . Young mice (3-4 weeks old) were
used for the FACs profile of the thymic development and older mice (6-8 weeks old) we used for rest of the
experiments. Littermates that were CD4-Cre negative were used as control mice.
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Figure 5: The CD4 Transgenic TCR Mice (2D2) Express Normal Levels of EHD Proteins and
Respond to MOG Peptide, but not the OVA Control Peptide. (A) Western blot of tissue lysates from
the thymus and spleen of 2D2 mice (T = Tg TCR), Wt TCR littermate (W = non transgenic), and EHD1
null mice (N = EHD1 null). N & W are used as control mice, M = marker. EHD3 membrane was striped
and re-probed for EHD2. 100 µg of tissue lysates were loaded in a 10% SDS PAGE gel. (B) Spleen cells
from littermate with WT TCR, the WT C57BL/6J, and the Tg TCR mice were cultured with either the
OVA peptide or the MOG peptide. Cells were pulsed with thymidine for the last 6 hrs of the 72 hrs
incubation. Cells were harvested and radioactivity was counted. C) CFSE labeling was also used to check
the specificity of the TgTCR. BMDC were pulsed with either the MOG peptide or OVA control peptide
then were co-cultured together with CFSE labelled freshly purified CD4+T cells (92%) from the TgTCR for
3 days. FACs analysis of day 0 and day 3 are shown. D) Purity level of CD4+ T-cells used in this
experiment. E) PCR of a mouse litter genotyped with DNA extracted from tails showing an example of 4
different offspring (#1, 2, 3, & 4) with or without CD4-Cre; TgTCR, and carrying EHD (1,3,4)

flox/flox

for

the conditional deletion of EHD1, 3, & 4 in T-cells. F) FACS profile of cells from different lymphoid
organs of TgTCR and control mice. Thymus showing % of CD4+ and CD8+ T-cells. Spleen showing % of
CD4+ and CD8+ T-cells and % of T-cells that were positive for Vα3.2 and Vβ11 (expressed only on T-cells
with TgTCR).
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(Fig. 5F) Continued,
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Figure 6: CD4-Cre Mediated Conditional Deletion of EHD 1, 3 and 4 does not Impact Thymic T-cell
Development but Leads to a Relative Decrease in CD4+ T-cells in Secondary Lymphoid Tissues. A)
Western Blot verification of EHD1/3/4 deletions is shown. Lysates of freshly isolated splenocytes from the
same mice before T-cell expansion were used as controls. A representative blot of N = 6 is shown. B & C)
There was no change in the absolute number of cells in the different lymphoid tissues of CD4-Cre+ mice.
In B) cell numbers were counted in single cell preparations of the indicated lymphoid organs of 4-week-old
CD4-Cre+ and CD4-Cre- (control) mice; N = 5. In C, the total spleen cell numbers from adult (6-8 weeks
old) mice are shown; N = 5. D & E) Analysis of thymic developmental stages in CD4-Cre+ and CD4-Cremice are shown. D) Top and middle panels show representative FACS plots with gating strategies used for
analysis of cell subsets and developmental stages in thymocytes of 4-week-old mice. The numbers in
quadrants represent the mean percentage of total thymocytes. Bottom shows quantification of middle panel.
E) Top shows FACS plots with gating strategies and bottom shows quantification of relative percentages of
cell subsets or cell numbers as in D), N = 4. F & G) Reduced percentages of T-cells in the spleen and
increased percentages of B cells in the spleen and LN are shown. Spleen (F) and LN cells (G) from 4week-old CD4-Cre+ and CD4-Cre- mice were analyzed by FACS for markers of B cells (B220 +), CD8+ Tcells and CD4+ T-cells (N=4). Total cell numbers were calculated by multiplying the total live cell counts
with the percentage of each subset. All values plotted as the mean ± SEM for indicated sample size. *,
p<0.05; **, p<0.01.
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Figure 7: Conditional Deletion of EHD 1, 3 and 4 in T-cells Leads to Reduced Cell Proliferation and
IL-2 Secretion. A) A reduced proliferation by Cell-Trace Violet dye dilution assay is shown. Successive
cell divisions were modeled with ModFit LT software and are shown as peaks of different colors. The
figure is a representative of N = 3. The mean percentages of cells at successive divisions are shown on the
right as a histogram. The proliferation index (PI) shown on top is the mean ± SEM of N = 3. *, p<0.05; **,
p<0.01; ***, p<0.001; ****, p<0.0001; *****, p<0.00001. B) Reduced proliferation seen by 3H-thymidine
incorporation assay is shown. Shown is a representative figure of N = 2. C) Cells were stimulated as
previously mentioned for the proliferation assays and stained with propidium iodide (PI) and anti-Annexin
V antibody followed by FACS analysis for relative proportions of PI +/Annexin V+ apoptotic cells. Values
represent mean ± SEM. of N = 2 (NS, not significant). D) Spleen cells from EHD1fl/fl; EHD3fl/fl; EHD4fl/fl;
CreERT2; 2D2Tcr mice were stimulated with anti-CD3/CD28 in the presence or absence of 4-OH-tamoxifen
(4-OHT) for four days to derive in vitro EHD 1/3/4-deleted T-cells vs. their WT controls. Cells were
washed, loaded with CFSE dye and re-stimulated with anti-CD3/CD28 for 72 hrs. Shown is a
representative figure of N = 2. E) Western blot used to show depletion of EHD 1/3/4 in tamoxifen-treated
T-cells. F) Quantification of the percentage of proliferating cells from the data shown in D). G) Reduced
IL-2 secretion is shown. Values represent mean ± SEM, N = 4, * p<0.05, **p<0.01). H) There was a
reduced severity of EAE in CD4-Cre+ mice. The plotted values are the composite mean scores ± SEM, N =
5 in each group, *, p<0.05. Clinical scores were recorded as described in Methods.
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Figure 8: Conditional Deletion of EHD 1, 3 and 4 Leads to Impairment of Basal Recycling of TCRCD3 from Endocytic Compartments to the Cell Surface. A) The surface level of TCR-CD3, CD28 and
LFA1 at steady state is shown. MFI values plotted are mean ± S. E. of N = 4 (*, p<0.05). B) A relatively
intact basal TCR-CD3 internalization is shown. N = 3; NS, not significant. C) Reduced recycling of preexisting endosomal TCR-CD3 is shown. The data represent mean ± SEM. of N = 4 (*p<0.05). D) The
recycling of the labelled cell surface TCR-CD3 is shown. Cells were analyzed by FACS and MFI values
used to quantify the proportion of internalized receptors that were still intracellular (acid wash-resistant
fraction) and the percent of recycling was calculated as described in Methods. Values plotted are mean ±
SEM of N = 4. *, p<0.05, **, p<0.01.
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Figure 9: Conditional Deletion of EHD 1, 3 and 4 Leads to a Reduced Level of the CD3Ɛ Component
of TCR-CD3. A) Expanded T-cells from LN of CD4-Cre- or CD4-Cre+ mice probed for CD3Ɛ and either
EHD1/4 or EHD3 proteins. B) Quantification of CD3Ɛ signals. Values plotted are mean ± SEM. of N = 5.
C) LN cells from EHD1fl/fl; EHD3fl/fl; EHD4fl/fl; CreERT2; 2D2-Tcr or EHD1fl/fl; EHD3fl/fl; EHD4fl/fl; 2D2Tcr
(control) mice were stimulated with anti-CD3/CD28 for four days in the presence (+) or absence (-) of 4OHT. Lysate from equal numbers of cells were loaded in each lane. Western blot was carried out as in B.
Shown is a representative blot run in duplicate. D) Quantification of CD3Ɛ signals for blot shown in C). E)
Quantification of CD3Ɛ signals for Cre-ERT+ T-cells. Values plotted are mean ± SEM of N = 3 *p<0.05,
**P<0.01.
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Figure 10: Conditional Deletion of EHD 1, 3 and 4 Leads to Lysosomal Degradation of TCR-CD3. A)
T-cells expanded from LN of CD4-Cre- or CD4-Cre+ mice (7-8 days) were washed and treated with (+) or
without (-) 100 nM Bafilomycin-A1 for 4 h at 37oC. Lysate from equal numbers of cells probed for CD3Ɛ
and EHD1/4 and re-probed for EHD3, with β-actin as a loading control. A representative blot is shown. B)
Quantification from data exhibited in A are shown here. Values plotted are mean ± SEM of N = 3. C)
Expanded T-cells from LN of CD4-Cre- or CD4-Cre+ mice were treated with Bafilomycin-A1 as in A and
stained with anti-CD3Ɛ (Red) and anti-LAMP1 (Green) antibodies followed by confocal imaging. Shown is
a representative image of N=3. Scale bar = 2 µm. D) Right, cells not treated with Bafilomycin-A, but
stained as those in C).The red boxes indicate that the intracellular pools of CD3Ɛ were used to determine
Pearson correlation coefficients from analyses of >50 cells per group as an indication of the extent of
CD3Ɛ/LAMP1 co-localization, which is shown in D, Left. Values are mean ± SEM, *p<0.05.
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10.

Summary of all the Studies
The endocytic trafficking pathways is a complex pathway used by all vertebrates. This

pathway is extensively used in critical processes such as cell migration (Maritzen et al., 2015;
Paul et al., 2015), receptor turn over (Irannejad et al., 2015), cell signaling (Barbieri et al., 2016;
Irannejad et al., 2015; Platta & Stenmark, 2011; Villasenor et al., 2016), cell-to-cell
communication (Onnis et al., 2016), and in other pathways such as pathogen invasion (Kulpa et
al., 2013; Pirooz et al., 2014; Takeuchi et al., 2011), cell division (Chesneau et al., 2012;
Schweitzer et al., 2011) , and membrane remodeling (Matsubayashi et al., 2015). It is well
documented that mis-regulation of the endocytic trafficking is linked to different diseases
including chronic hepatitis B virus (HBV) infections (Macovei et al., 2013; Watanabe et al.,
2007), cancer (Mellman & Yarden, 2013; Mosesson et al., 2008), HIV infection (Kulpa et al.,
2013), autoimmune diseases (Iglesias-Bartolome et al., 2009), etc. Therefore, understanding how
regulators of this complex pathway function is of great interest in basic and clinical immunology.
On a cellular level, cells use this pathway for various reasons including the internalization
of receptors and uptake of nutrients, ligands, other molecules and viruses. Cells use different
routes to endocytose materials that include the clathrin-dependent pathway and the clathrinindependent pathway. However, regardless of the pathway, the internalized receptors enter the
early endosome (EE) where they are sorted for either traffic into late endosome/MVB and
lysosome or for recycling back to the cell surface. This pathway is regulated by a few families of
regulators such as Rab family of GTPases and more recently a growing number of researchers
have demonstrated that the EHD protein family is among key regulators of this complex pathway.
Our group and others have studied the role of EHD proteins both in vitro and in vivo.
They regulate the transport of various receptors from different steps of the endocytic trafficking
pathway. They have been shown to regulate the recycling of receptors from the EE to the RE, the
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EE to the LE, and the retrograde transport through the Golgi. In non-immune cells systems, EHD
proteins have been shown to regulate the transport of some key receptors such as MHC-I, TfR,
and MHC-II that have been demonstrated in immune cells, to accumulate at the immunological
synapse and be essential for the formation and maintenance of the IS (Caplan et al., 2002; Lin et
al., 2001; Naslavsky & Caplan, 2011; Walseng et al., 2008). In addition, EHD proteins have been
shown to regulate the neuronal synapse (Das et al., 2004; Ioannou & Marat, 2012; Ioannou &
Marat, 2012; Jakobsson et al., 2011; Lasiecka et al., 2010; Valdez et al., 2005; Wei et al., 2010;
Yap et al., 2010), the neuromuscular junction (Mate et al., 2012) , and the process of ciliogenesis
(Bhattacharyya et al., 2016). All of these process have been demonstrated to exhibit various
similarities with the immunological synapse (Bezakova & Ruegg, 2003; Boulanger et al., 2001;
Dustin & Colman, 2002; Finetti et al., 2009; Finetti et al., 2014; Griffiths et al., 2010; Tarakanov
& Goncharova, 2009). However, though there is growing number of researchers interested in
studying this family of proteins, their roles in immune cell functions were never investigated.
Immune surveillance and rapid response by the immune system is essential to eliminate
invading infectious agents and endogenous oncogenically-transformed cells. T-cells are major
regulators and executioners of these functions. Effective generation of an immune response
requires concurrent engagement of and signaling through co-stimulatory proteins (e.g., CD28) on
T-cells by their cognate ligands on the APC surface (Huppa et al., 2003). Therefore, the
mechanisms that ensure optimal levels of the TCR and accessory receptors on the T-cell surface
prior to antigen stimulation are fundamentally critical to generating an effective immune
response. However, mechanisms that regulate the surface pool of TCR and its accessory receptors
have been primarily investigated in the context of T-cell activation.
During T-cell activation, TCR signaling elicited by the APC-presented antigen, together
with co-stimulatory signals, leads to spatial reorganization of the TCR and accessory receptors,
such as CD28 and LFA-1, to form an area of intimate contact with APCs, the IS (Hashimoto-
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Tane et al., 2010; Jo et al., 2010). The endocytic pathways supply the IS with newly-synthesized
and recycled receptors to replenish those that are targeted to the lysosome for degradation (Das et
al., 2004; Lee et al., 2003; Valitutti et al., 1997) . T-cell receptors such as TCR-CD3 (Huppa et
al., 2003), CD28 (Cefai et al., 1998) and LFA-1 (Fabbri et al., 2005; Stanley et al., 2012) are
known to be internalized and recycled to the IS during T-cell activation. Internalized TCR-CD3
traverses the Rab5+ EE, followed by transport through Rab4+ and Rab11+ endosomes, indicating
the involvement of both fast and slow recycling pathways (Kumar et al., 2011; H. Liu et al.,
2000). Naïve and resting T-cells constitutively internalize and recycle their surface receptors and
the balance of these processes dictates their pre-stimulation surface levels and hence the levels of
T-cell activation (H. Liu et al., 2000). Yet, the mechanisms of constitutive basal traffic of TCRCD3 are not fully understood.
Based on the importance of the endocytic traffic in T-cell function and IS formation and
maintenance, we wanted to investigate the role of the EHD proteins in both T-cell function and in
the IS. Given the importance of the endocytic trafficking in T-cell function and in IS during
activation and the role the EHD proteins in the neuronal synapse, in neuromuscular junction, and
in ciliogenesis, we hypothesized that EHD protein will regulate the endocytic recycling of
receptors in unstimulated and activated t cells respectively.
Our group and others have shown that EHD proteins are expressed in spleen, so to
expand on this, we checked the expression of EHD proteins in the spleen, thymus and in lymph
nodes using western blotting and immunofluorescence staining. Our data confirmed previous data
and also showed in other lymphoid organs that were not published before that all members of the
EHD proteins family are expressed in all lymphoid organs tested (Fig. 1). We then check their
expression levels in primary T cells and cell lines. We show for the first time that multiple EHD
proteins family members are expressed both in primary CD4+T-cells and in Jurkat cell line. This
was shown both through western blotting and IF (Fig.1 and not shown).
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To determine if EHD protein were important during T-cell activation, we stimulated
freshly isolated CD4+T cells with or without anti-CD3/CD28 for 2 days and check the levels of
EHD proteins at different time points. In our surprise, we saw that EHD1 and EHD4 levels went
up over time with stimulation, while the level of EHD3 went down (Fig. 2). These results
suggested that EHD proteins are important in T cell functions.
We have used gene targeting in mice to reveal the in vivo functional roles of EHD
proteins and cell surface receptors whose traffic is regulated by EHDs (Curran et al., 2014;
Cypher et al., 2016; Demonbreun et al., 2015; Doherty et al., 2008; Gudmundsson et al., 2010;
Posey et al., 2011; Posey et al., 2014) in other systems. We have previously generated single and
combination knockout of EHD protein family. For example, EHD1 KO mice exhibit straindependent phenotypes varying degrees of embryonic lethality, male infertility, ocular
developmental defects, and neural tube closure defects due to impairment of ciliogenesis and
SHH signaling (Arya et al., 2015; Bhattacharyya et al., 2016). EHD3 null mice have cardiac
abnormalities including arrhythmias and blunted response to adrenergic stimulation, and reduced
expression of Na/Ca exchanger (NCX1) (Curran et al., 2014). EHD4 null mice showed that EHD
4 was required for normal pre-pubertal testis size in male and these males had reduced fertility.
Whenever these mice were analyzed, they did not show any obvious immune defect phenotypes.
A closer look at the CD4+T-cells from EHD1 and EHD4 null mice showed that deletion of EHD1
protein individually did not cause a significant impact on T cell activation; however, deletion of
EHD4 individually showed a decrease in T cell proliferation.
Given the likelihood of redundant EHD function, we generated mice with a CD4-Credepepndent, T-cell directed, conditional deletion of floxed Ehd1, Ehd3, and Ehd4 genes. To
examine the impact of EHD 1/3/4 deletions in T-cells in the context of antigen-specific responses,
we also incorporated the MOG peptide-specific 2D2-Tcr transgene (Bettelli et al., 2003) into our
conditional knockout model. Analysis of thymic T-cell development did not reveal any
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significant alterations in total cellularity, T-cell subsets or relative proportions of T-cells at
different stages in mice with a CD4-Cre mediated deletion of EHD1/3/4, indicating that EHD
proteins are largely dispensable for thymic development beyond the CD4/8 double-positive stage.
One limitation of this model is the fact that there is still one member present in these T-cells, so
whether this might reflect any role of the remaining EHD family member, EHD2, remains a
possibility that will require future studies. The second limitation of our model is that we are using
CD4-cre in which deletion take place at the CD4/8 double positive. It is still possible that EHD
proteins are important at earlier stages of thymic development and future use of other Cre
elements active at those stages will be needed to address this possibility. The third limitation of
our models is the fact that our analyses were carried out in the context of a pre-rearranged TCR
transgene; this could have masked a potential developmental role of EHD proteins in the context
of a normally diverse TCR repertoire. More analysis of the thymic development is being
conducted at this point to check if EHD proteins have any role during thymic development
beyond the double positive stage of T-cell development.

In contrast to the relatively unperturbed thymic development, CD4-Cre mediated
EHD1/3/4 deletion led to a decrease in the percentage of T-cells in the periphery. This phenotype
was seen in secondary lymphoid tissues, including the lymph nodes and the spleen. These results
suggested that EHD proteins might play a more important role in mature peripheral T-cells. In
addition, an apparent increase in the peripheral B cell numbers and their percentages was seen.
The basis of this phenotype is unknown but is likely to reflect altered T-cell- B-cell interactions
due to T-cell deficiency of EHD1/3/4.

The in vitro analyses of T-cells from the CD4-Cre deletion model demonstrated
significantly defective antigen-elicited CD4+ T-cell proliferation and IL-2 cytokine secretion
responses upon EHD1/3/4 deletion. Similar results were observed using CD4+ T-cells derived
from an alternate model where in vitro deletion of floxed EHD1, 3 and 4 genes was induced with
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4-OHT to bypass any in vivo developmental abnormalities. These results support a T-cell intrinsic
positive role of EHD proteins in sustaining antigen-driven T-cell responses in mature peripheral
T-cells, a role independent of any potential involvement of EHD proteins in events associated
with thymic T-cell development.

Research has shown that self-reactive T-cells from patients with multiple sclerosis and
type1 diabetes form impaired IS. Their T-cells had TCRs signaling in the periphery with little or
no accumulation of pMHC or TCR-pMHC complex transport to the cSMAC (Schubert et al.,
2012). Our antigen specific model, the 2D2 mouse model, is a well-established and accepted
animal model of EAE which recapitulates many aspects of MS and has led to the development of
different therapies approved for treatment of MS (Steinman & Zamvil, 2006). Understanding the
trafficking mechanisms that ensure the polarized display of cell surface receptors in the IS will
enhance our understanding of a key process in immune responses and could provide new
approaches of immune intervention in highly prevalent diseases such as cancer and autoimmunity
(Derniame, Vignaud, Faure, & Bene, 2008; Nicolaou et al., 2007).

Coordination of multiple EAE-inducing T-cell functions, including their early activation,
expansion, migration to the brain across the blood/brain barrier, and effector functions to mediate
demyelination in the CNS are required for full disease induction (Furtado et al., 2008; O'Connor
et al., 2008). It is important to note that about 4% of the 2D2 mice develop spontaneous EAE by 3
to 5 months of age; however, all the mice used for these studies were 6-8 weeks old and the
disease was induced by immunization with the MOG peptide. We analyzed the impact of
EHD1/3/4 deficiencies on the onset and progression of EAE. Since in vitro studies showed the Tcell proliferation and cytokine (IL-2) secretion to be impaired upon EHD1/3/4 deficiencies, we
expected to see a delayed onset and reduced severity of EAE. While we saw no difference in the
onset of disease, EHD1/3/4-null mice showed a decrease in the disease severity compared to
control littermates.
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Our studies on the importance of EHD proteins in IS formation and maintenance showed
that EHD1 and EHD3 accumulate at the IS (T cell-APCs contact site) during T-cell activation
(data not shown). Although our analysis never showed if the deletion of EHD proteins in T-cells
could lead to impaired IS formation, the accumulation at the IS that we observed in our WT Tcells still suggest that EHD could be required for the traffic of key receptors and integrin such as
TCRs, CD28, CD25, and LFA-1in the IS. Again, these data suggest that EHD could have an
important role in the IS as those CD4+ T-cells have to be activated first, then migrate to the brain
to cause demyelination of the CNS. Therefore, these results demonstrate that EHD proteins play a
functional role in T-cells in vivo. Further in vitro and in vivo studies using models developed here
should help to comprehensively reveal other aspects of T-cell function that also rely on EHD
protein expression.

Given the reduced TCR-CD3 levels in the CD4+T-cells of our EHD1/3/4 -null mouse
model prior to deliberate T-cell activation, our focus was on the role of EHD proteins in basal
(prior to antigenic stimulation) TCR-CD3 traffic, which has not been mechanistically dissected in
much detail. Therefore, further studies to identify partner proteins through which EHDs regulate
TCR traffic will be of great interest. Notably, endocytic trafficking pathways play key roles
during T-cell activation by orchestrating the polarized transport of TCR-CD3 and signaling
molecules such as Lck to maintain an active immunologic synapse, and Rab4- and Rab11positive endosomes are implicated in these processes (Soares et al., 2013).

To assess whether EHD proteins regulate the traffic of TCR-CD3 or the accessory
receptors, we first examined the cell surface levels of TCR-CD3, CD28, and LFA-1 by FACS
analysis of unstimulated T-cells. T-cells from CD4-Cre+ mice expressed significantly lower levels
of TCR-CD3 on the cell surface compared to T-cells from control mice (Fig 8A). When we
analyzed in vitro activated CD4+ T-cells from CD4-Cre+ mice, we saw that they expressed lower
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levels of TCR-CD3, CD28, CD25, CTLA-4 and LFA-1 compared to those from control mice. We
also checked the levels of CD4 both in non-activated and activated and it did not change.

Since EHD proteins are regulators of the endocytic trafficking pathway, we examined the
kinetics of TCR-CD3 internalization and recycling in unstimulated CD4+ T-cells. Analysis of
TCR-CD3 internalization using FACS showed that there was not significant difference in
internalization of TCR in EHD1/3/4 -null T-cells compared to control T-cells (Fig. 8B). However,
these T-cells exhibited a significantly reduced recycling of both the pre-existing intracellular pool
of TCR-CD3 and the PE-labeled surface TCR-CD3 (back) to the cell surface at all-time points
analyzed compared to control T-cells. Overall, these results show a key requirement of EHD 1, 3
and 4 in basal recycling of TCR-CD3 from intracellular endocytic recycling compartments back
to the cell surface.

We were also interested in checking the total level of TCR-CD3 in these EHD1/3/4-null
T-cells (from CD4-Cre-mediated and 4OHT-induced ERT-Cre deletion). Were examined the
total levels of CD3Ɛ by western blotting and we found that deletion of EHD proteins led to a
significant decrease in the total levels of CD3Ɛ (Fig. 9). Given our findings with the CSF-1
receptor in macrophages (Cypher et al., 2016), we hypothesized that this reduction was likely due
to lysosomal targeting and degradation. To test this hypothesis, we treated the EHD1/3/4-null Tcells with or without bafilomycin-A1, an inhibitor of lysosomal degradation, for 4 h and analyzed
the impact on total CD3Ɛ levels using western blotting and confocal. Western blot of cells treated
with Bafilomycin A1 for 4 h showed a recovery of the CD3Ɛ protein level in EHD1/3/4 -null Tcells, with levels in treated cells comparable to those in control cells. Confocal imaging of
control and EHD1/3/4 -null T-cells incubated with or without bafilomycin-A1 showed that
relatively low CD3Ɛ staining was co-localized with the lysosomal marker LAMP-1 in untreated
cells, but some co-localization was also seen in Bafilomycin A1-treated control T-cells. However,
we saw significantly more lysosome-localized CD3Ɛ in EHD1/3/4-null cells treated with
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bafilomycin-A1. These data suggested that EHD proteins promote the recycling of the TCR-CD3
while preventing their lysosomal degradation.

11.

Conclusions

Overall, studies presented here using genetic models and functional analyses in vivo and
in vitro, reveal an important albeit redundant positive role of the newly-described EHD family of
endocytic recycling regulatory proteins in T-cell function. Mechanistically, we show that EHD
proteins are required to facilitate basal recycling of TCR-CD3 from intracellular endocytic
compartments back to the cell surface to ensure the surface expression of optimal TCR-CD3
levels for subsequent antigen-driven T-cell activation. Our founding support the conclusion that
expression of EHD1/3/4 is required for efficient transport of TCR-CD3 from endosomal
compartments back to the cell surface and to prevent its aberrant traffic into lysosomes.

We also show that EHD1 and EHD3 accumulate at the IS (data not shown). These data
suggest that EHD proteins could regulate the transport of important receptors and signaling
molecule at the IS during T-cell activation. Altogether, our studies support the role of EHD
proteins both before and during T-cell activation. Future studies using the unique models
described here should add to our understanding of the importance of endocytic traffic in the
control of TCR-CD3 and other receptors that regulate T-cell functions as well as the roles of these
proteins in other cells in the innate and adaptive arms of the immune system.

12.

Future Directions
Although our studies have reveal novel role of EHD proteins in T-cell function, there are

still many questions that are left unanswered. Our model system used the deletion of EHD1,
EHD3, and EHD4, while leaving EHD2 untouched. Although CD4+ T-cells express a low level of
EHD2, it still does not rule out the possibility that EHD2 could have some role in T-cell function.
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It will therefore be important to check that function of EHD2 either using the EHD2 null mice or
using the inducible system established in our laboratory. Another question that is left unanswered
is the actual role of each of the EHD proteins deleted in our system. Although initial studies were
done using the EHD1null mice showed no significant difference compared to WT mice, initial
studies using EHD4 null mice showed that their T-cells have a decreased proliferation compared
to control T-cells. It will be interesting to check if T-cells from EHD3 null mice will have no
difference in proliferation compared to control T cells since EHD3 seems to be used differently
than other EHDs during activation.
Our analysis of young mice showed that the percentage and absolute number of B cells
increased in both the spleen and lymph nodes. The basis of this phenotype is not known. It will be
great interest to investigate which sub-type of B cells caused this increase and to also check if
their functions were affected. We also saw a slight change in the percentage of CD8+T-cells;
however, since our model (2D2 mice) is known to be skewed toward the CD4+ T-cell
compartment, it makes it difficult to know what role EHD proteins have in CD8+ T-cells. The use
of a non-transgenic model to study thymic development and different T-cell sub-sets in the
periphery is needed.
We have analyzed some T-cell surface receptors such as CD28, LFA-1, CD25, and
CTLA-4 and saw that deletion of EHD proteins led to their decrease from the cell surface. It will
be interesting to study the role of EHD proteins in the traffic of CTLA-4, since they localize in
endosomes in unstimulated T-cells and must be transported to the cell surface during T-cell
activation.
The mechanism by which EHD proteins regulate the traffic of TCR-CD3 is not known.
Since either the TCR or the CD3Ɛ themselves do not contain NPF motifs, it suggest that there is
another protein that links or associate them to endosomes positive for EHD proteins to regulate
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their recycling back to the cell surface. It will be interesting to investigate which proteins link
EHD proteins to TCR-CD3 for their transport.
Our confocal analysis showed EHD protein expression in APCs (data not shown). Since
we have an in vitro inducible system, we can study the role of EHD proteins in APCs. Also
further studies to examine the potential importance of EHD proteins in regulating endocytic
traffic into and out of the IS during T-cell activation will be of great interest. In this regard, our
group and others have recently identified a key role of EHD proteins in primary cilia biogenesis
(Bhattacharyya et al., 2016; Lu et al., 2015). Recent studies have shown that the maintenance of
IS in cilia-less T-cells involves ciliogenesis-related proteins such as IFT20 which localize in the
IS and are required for recycling of TCR-CD3 (Finetti et al., 2009; Finetti et al., 2014; Finetti et
al., 2015). Although IFT20 KO under CD4-Cre led to only minor defects in T-cell development
and collagen- induced arthritis (an experimental model of rheumatoid arthritis), earlier deletion
using Lck-Cre led to defective thymic development and T-cells function in vivo (Yuan et al.,
2014); the latter are partially similar to the phenotype of our EHD1/3/4 KO mice. Interestingly,
the requirement of EHD1 and EHD3 were found to be important for the recruitment of transition
zone proteins and IFT20 during ciliary vesicle formation (Lu et al., 2015). Though our study has
been done mainly on freshly isolated and rested cells, it seems plausible that EHD proteins may
also regulate the traffic of TCR-CD3 in the IS to promote T-cell activation and subsequent
responses.
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